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ABSTRACT
The effect of opiates on the uptake and release of neuro-
transmitters was studied with rat brain synaptosomes. In general,
the uptake of monoamines is more sensitive to alkaloid opiates
while the amino acid neurotransmitters are more sensitive to the
opioid peptides. Among the opiates tested, methadone is the most
potent inhibitor for the uptake of neurotransmitters. The inhibition
is caused by interaction between methadone and the transport
carriers thus decreasing the affinity between the amines and their
respective carriers. As the inactive opiate--dextrorphan is as
potent as methadone and that naloxone fails to reverse the effect
of the active opiates, it seems that opiates do not exert their
central actions by modulating the re-uptake of neurotransmitters
at nerve terminals. On the other hand, active opiates are active
in stimulating the evoked release of neurotransmitters, and dextror-
phan has no effect, it is possible that opiates exert their central
actions by stimulating the release of neurotransmitters, and these
actions are likely mediated by presynaptic opiate receptors. As
the opiates tested fail to alter the release of adenosine, involve-
ment of this neurotransmitter in the central actions of opiates
appears to be rather unlikely. However, adenosine may interact with









S-receptor Subtype of opiate receptor with
high affinity to alkaloid opiates
S-receptor Subtype of opiate receptor with
high affinity to enkephalins
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1CHAPTER I GENERAL INTRODUCTION
Opiates and Opioid Peptides
In this thesis, opiates, opioids and narcotics are terms
used interchangeably to designate drugs, natural and synthetic,
with morphine-like actions. These substances bind specifically
to any of several subspecies of opioid receptors and produce
some agonistic actions. Some substances, like naloxone and
levallorphan, appear to bind to receptors for opioids but
initiate little agonistic action they are designated as opiate
antagonists. Met-enkephalin, leu-enkephalin and -endorphin
belong to the class of compounds which are designated as
endogenous opioid peptides. These compounds together with their
synthetic analogs possess opiate-like properties, especially
analgesia.
Morphine and related opiates produce their major effects
on the central nervous system (CNS) and the bowel. These
diverse effects include analgesia, drowsiness, changes in
mood, respiratory depression, decreased gastro-intestinal
motility, nausea, vomiting, and alternations of the endocrine
and autonomic nervous system. These actions are thought to
mediate through opiate receptors and neurotransmitters
(Kosterlitz et al., 1973 Braude et al., 1974 Duggan et al.,
1976 Loh et al., 1976 Jessell and Jversen, 1977 Adler et
al., 1978 Kosterlitz and Hughes, 1978 Adler, 1982).
21.1 Opiate Receptors
Opiates act as agonists, interacting with stereospecific
and saturable binding sites or receptors in the brain and
other tissues. These binding sites are widely but unevenly
distributed throughout the CNS. They are present in highest
concentration in the limbic system (frontal and temporal
cortex, amygdala, and hippocampus), thalamus, striatum,
hypothalamus, midbrain, and spinal cord (Snyder et al., 1974
Simon and Hiller, 1978). Some of these areas such as the
periaqueductal gray matter, the thalamus, the limbic system
and the substantia gelatinosa are specifically associated
with pain-mechanisms (Hiller et al., 1973). This finding
suggests the analgesic action of opioids.
Receptor binding studies with different isolated tissue
preparations, such as guinea-pig ileum and mouse vas deferens,
suggest that different populations of opiate receptors exist
in the brain and peripheral tissues (Lord et al., 1977). For
instance, typical morphine agonists are more potent in the
guinea-pig ileum they are equally well antagonized by naloxone
in both the guinea-pig ileum and mouse vas deferens and are
more effective in displacing 311-naloxone, 3H-naltrexone, or
3H-dihydromorphine than 3H-leu-enkephalin. These receptors
have been designated p-receptors (Lord et al., 1976 Lord
et al., 1977). The enkephalins and some enkephalin analogues
are thought to interact with 6-receptor. The S-agonists are'
3more potent in the mouse vas deferens and are not so readily
antagonized by naloxone in this preparation as in the guinea-
pig ileum. The 6-receptor agonists are also more effective in
displacing 3H-leu-enkephalin than 3H-naloxone or 3H-naltrexone.
It appears that the guinea-pig ileum contains a greater
proportion of p-receptors while the mouse vas deferens contains
mainly 6-receptors. In the CNS, autoradiography indicates
differential localizations of the u- and d- receptors,
suggesting that they mediate different neuronal functions
(Goodman et al., 1980). The p-receptors have been proposed to
mediate analgesic actions, while 6-receptors preferentially
regulate emotional behaviors. The former proposal has been
investigated taking advantage of the fact that naloxone can
antagonize the binding of morphine agonists to the p-receptors
and reports in agreement with this proposal have appeared.
For instance, studies with animals have shown that stimulation-
produced analgesia (SPA) is blocked partially by naloxone, and
the reversal of stimulation-produced relief of pain by naloxone
has also been demonstrated in man (Hosobuchi et al., 1977).
Moreover, naloxone can exacerbate the symptoms in patients with
pain (Levine et al., 1978).
1.2 Opioid Peptides and Opiate Receptors
Peptides that show opiate-like properties have been
isolated from brain and pituitary. Met-enkephalin and leu-
enkephalin were isolated from brain (Hughes et al., 1975
Simantov and Snyder, 1976), while the larger endorphins such
4as -endorphin were isolated from extracts of hypothalamus
and pituitary (Bradbury et al., 1976 Cox and Goldstein, 1976
Ling et al., 1976). The morphinomimetic activity of the
endorphins and enkephalins has been studied extensively in the
guinea-pig ileum preparations (Hughes et al., 1975 Ling et al.,
1976), and in synaptosomal preparations.using.stereospecific
opiate-receptor binding assays (Simantov and Snyder, 1976
Lazarus et al., 1976), and in behavioral studies after injection
into cerebrospinal fluid (Loh et al., 1976Wei and Loh, 1976
Bloom et al., 1976).
Radioreceptor assay showed that enkephalin was localized
in nerve endings, which is consistent with a neurotransmitter
role, that its detailed regional distribution in brain closely
paralleled that of opiate receptors, and that its phylogenetic
distribution was the same as that of opiate receptors (Simantov
et al., 1976). Enkephalin is released in a calcium-dependent
fashion following depolarization,which further supports--a
neurotransmitter role of these peptides (Smith et al., 1976
Puig et al.,1977 Henderson et al., 1978).
Parallel localizations of opiate receptors and enkephalins
can explain many of the pharmacological actions of opiates
(Atweh and Kuhar, 1977 Pert et al., 1976 Simantov et al.,
1977 Uhl et.al., 1979 Watson and Barchas, 1979). For instance,
the finding that small enkephalin-containing interneurons in
the dorsal spinal cord and the presence of opiate receptors in
5nerve endings of sensory neurons suggest that the interaction
may inhibit the release of sensory pain neurotransmitters,
such as substance P (Jessell and Iversen, 1977). Moreover,
microinjection of opioids into the substantia gelatinosa
suppresses the activity elicited in lamina V of the spinal
cord by noxious stimulation (Duggan et al., 1976), and
stimulation-produced analgesia in human has been demonstrated
at sites that are rich in both enkephalins and -endorphin
and that endogenous peptides have been shown to release into
the cerebrospinal fluid during stimulation (Akil et al., 1978)
In addition, the presence of enkephalin tracts and opiate
receptors in the limbic system, which regulates emotional
behaviors-may explain euphoric effects of opiates.
Though met-enkephalin and leu-enkephalin are very similar
in their structures, they occur in completely distinct neuron:
in brain and intestine (Larsson, 1979), and the patterns of
distribution of these two peptides differ considerably. Based
on this and other findings Goodman et al. (1980) separately
proposed that there.are two types,:-,of-opiate-receptors which
interact with met- and leu-enkephalins. It has been further
suggested that the two types of enkephalin neurons may be
involved in different brain functions. In support of this
notion is the finding that brain regions with more p than S
receptors, such as the hippocampus and thalamus also have
more met-enkephalin neurons than leu-enkephalin neurons
(Goodman et al., 1980), while the substantia gelatinosa and
6the caudate, which have similar levels of p and 6 receptors,
also have similar. concentrations of met-enkephalin and leu-
enkephalin (Goodman et al., 1980).
1.3 Actions of Opioids
Specificity of opiate receptors suggests that the binding
of an exogenous opioid agonist or an endogenous ligand to its
receptor initiates the events that ultimately produce the
analgesic and behavourial effects observed. Several hypotheses
have been proposed to explain the central action of opiates.
Some of them are outlined briefly below.
Opioid agonists as well as the endogenous opioid peptides
have shown to decrease the activity of adenylate cyclase,
thus cyclic AMP formation,in cultures of nerve cells. Cyclic
AMP has been shown to be a second messenger of central mono-
aminergic neurotransmission (Bloom, 1976). This inhibitory
effect is antagonized by naloxone. Moreover, when cells are
made tolerant to morphine for several days, the activity of
adenylate cyclase and concentrations of cyclic AMP decreased
first then returned to the baseline values opiate withdrawal
enhanced the activity of adenylate cyclase, and cyclic AMP
formation (Sharma et al., 1975). Studies with slices prepared
from various brain regions also show similar effects.
According to these authors, opiates may exert their actions
7in the CNS by interfering the adenylate cyclase system. In
relation to this proposal, Tsang et al. (1978) observed that
opiates inhibit the noradrenaline-induced cyclic AMP formation
in the cerebral cortex and hypothalamus homogenates of rat
brain, and this effect can be reversed by naloxone. They
proposed that opiates exert their central actions by inter-
fering with noradrenergic and possibly other neurotransmitter
systems.
The affinity of opioids for receptors in vitro is related
to the concentration of Na+, but not to that of other mono-
valent cations. Elevation of Na+ concentration reduces the
affinity of binding of agonists, while increasing that of
antagonists (SrryLder,, 1978). The physiological significance
of these observations is not apparent.
Electrophysiological studies of opiate and opioid
peptide action show that activation of opiate receptors leads
to an' inhibition of spontaneous 'firing- of neurons (Fre_derickson
and Norris, 1976 Zieglgansberger et al., 1976 Nicoll et al.,
1977 Gent and Wolstencroft, 1976), firing induced by
glutamate (Zieglgansberger et al., 1976), and nociceptive
nerve stimulation (Hill and Pepper, 1978 Duggan et al., 19761.
More detail studies on the Renshaw cells (Davies and Dray,
1976) and hippocampal pyramidal cells (Nicoll et al., 1977)
revealed that opioid peptides and opiates elicit excitatory
responses and these authors proposed that the excitation of
8hippocampal cells, at least, is probably resulted from
disinhibition of GABA input onto these cells (Zieglgansberger
et al., 1979). This finding suggests that opiates may exert
their central action by interacting with other neurotransmitter
systems.
Besides the above possible mechanisms of actions on post-
synaptic sites, opiates have been shown to decrease neuro-
transmitter release at-presynaptic terminals and this argues
for. a presynatic site of action. Briefly, opioids and
endogenous opioid-like peptides inhibited the release of
acetylcholine, noradrenaline, and substance P and alter the
release of dopamine in various neuronal preparations (Snyder,
1978 Terenius, 1978).
The fact that opioids alter the release of a number of
neruotransmittors suggests that they may influence some
mechanism that is fundamental to neuronal function, such as
transport of Ca++. It has been shown that administration of
morphine produces a depletion of Ca++ in the brain and
prevents uptake of Ca++ into brain slices and synaptosomes.
Moreover, calcium ion antagonizes the analgesia produced by
morphine (Way, 1978).
In conclusion, the actions of opioids in the CNS are
diversified, involving opiate receptors, adenylate cyclase,
Na+ participation, Ca++ transport and other neurtransmitter
9systems. Opi.oids probably affect the release and re-uptake
processes of various neurotransmitters in nerve endings
(Snyder, 1978 Hug and Oka, 1971 Ciofalo, 1972).
The Central Neurotransmitters
It is now well established that information processing
in the central nervous system largely involves communication
among neurons through release of neurotransmitters at synapses
(Eccles, 1964 Kriijevic, 1974). A synapse includes a presynaptic
nerve ending, a synaptic cleft several hundred A wide, and
a sensitive region of postsynaptic membrane. In the past
twenty or thirty years, a large number of miscellaneous
substances. have been proposed as central neurotransmitters
(Krnjevic, 1974 DeFeudis, 1975 Burnstock, 1976). Among them
are the amines: acetylcholine (ACh), noradrenaline (NA),
dopamine (DA), and 5-hydroxytryptamine (5-HT), and amino acids
such as y-aminobutyric acid (GABA), glutamic acid, aspartic
acid and glycine. Recently, adenosine and numerous peptides
such as the enkephalins and substance P (Snyder, 1980) are
also considered as neurotransmitter candidates in the brain.
After being released, the transmitter diffuses across the cleft
and binds to specific receptors on the post-synaptic membrane.
This binding causes conformational changes in the receptors
of the membrane, resulting in alternation in ion permeabilities.
The resultant ionic fluxes change the membrane potential of
the postsynaptic neuron and either bring the cell closer to
firing (excitation) or keep it from firing (inhibition).
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Transmitter action is terminated by removal of transmitter via
active uptake processes located in the presynaptic nerve endings.
In cholinergic neurons, however, the termination is achieved
by the action of acetylcholine esterase located in the
postsynaptic membrane.
1.4 Criteria for Identifying Central Neurotransmitters
Since Werman's article on the criteria for central
transmitters (Werman, 1966), much information has been gained
regarding the mechanisms by which neurotransmitters are taken
up, released and stored in synaptic vesicles. With reference
to such a perspective, several criteria have been proposed to
identify central transmitters. They are briefly outlined below
When a suitable amount of a transmitter candidate is
applied extracellularly in the vicinity of a neuron, it can
produce postsynaptic actions identical with those of the
transmitter normally released at that synapse (Werman, 1972).
A transmitter is released from presynaptic axons or
equivalent structures when stimulated by physiological, electrical
or chemical means (De Belleroche and Bradford, 1972 De
Belleroche et al., 1976 Blaustein, 1975 Blaustein et al.,
1972 Mulder et al., 1975),,and the amount released is in
proportion to the magnitude of stimulation. The release process
shows a true dependency on extracellular calcium concentration
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(Valdes and Orrego, 1978). For instance, the amount of 3H-
noradrenaline release induced by potassium, 46 mM is proportional
to extracellular calcium up to a concentration of 1.5-2.0 mM
(Vargas and Orrego, 1976 Vargas et al., 1977). Moreover,
absolute calcium requirements have also been found for
electrically induced release of labelled ACh (Somogyi and
S zerb, 1972) and 5-HT (Saldate and Orrego, 1975).
Transmitters have been shown to be contained in synaptic
vesicles. Electron microscopy studies revealed the presence of
small vesicles in variable numbers and with various sizes
and densities in the presynaptic terminals. Combined
morphological and biochemical studies have shown that ACh
is closely associated with a population of clear vesicles, and
noradrenaline with dense-core vesicles (Whittaker, 1969).
However, such an association has not been clearly demonstrated
in the case of the amino acid transmitters, although clusters
of vesicles are seen in electron micrographs of the synaptic
terminals which presumably use amino acids as transmitter. It
is believed that transmitters are stored in highly concentrated
synaptic vesicles to protect them from degradation by extra-
vesicular enzymes. Besides acting as protective organelles,
synaptic vesicles form part of a signal amplification
mechanism (Eccles, 1964 Kuffler and Yoshikami, 1975). In
addition, release by exocytosis also represents an efficient
mechanism for transferring, simultaneously, a large number of
highly polar molecules like the transmitters from intra- to
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extracellular sites. Otherwise, the passage of such molecules
across plasma membranes would be slow and prolonged. The
participation of synaptic vesicles in release mechanism
have been shown unambiguously for biogenic amine transmitters
(De Potter et al., 1969 Gewirt2, and Kopin, 1970 Ceccarelli
et al., 1973 Zimmerman and Whittaker, 1974), tihile evidence
for other transmitters are less solid.
Additional criteria often proposed for identifying
transmitters include demonstrations of synthesis, inactivation
of the transmitter candidate at presynaptic terminals, and
differential distribution of these mechanisms in the CNS. In
the case of transmitter biosynthetic enzymes, they are believed
to be transferred from their sites of synthesis in the cell
bodies down the axons to presynaptic endings (Dahlstrom, 1971
Banks and Mayor, 1973). Precursors for transmitter synthesis
are obtained from the extracellular environment in the vicinity
of presynaptic regions, by transport processes (Collier
and Katz, 1974). This belief is supported by the finding
that high affinity and sodium-dependent plasma membrane
transport mechanisms, with a considerable degree of specificity,
have been found in presynaptic endings (Snyder et al., 1970
Bennett et al., 1973). On the other hand, in cholinergic
neurons, acetylcholine released into the synaptic cleft is
degraded by cholinesterase to acetic acid and choline, the
latter is then. re-taken up into the terminals by high affinity
uptake system (Haga and Noda, 1973 Sorimachi and Kataoka,1974).
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Since the CNS is highly heterogeneous in form and function,
neuronal systems that differ in their transmitters, and hence
in their functions, should be present in different proportions
in different regions. Indeed, differential regional distribution
of transmitters such as catecholamines, indoleamines, acetyl-
choline and some transmitter peptides has been demonstrated
(Hildebrand et al., 1971). However, for amino acid transmitters,
which mediate the ubiquitous functions of central excitation
or inhibition, as well as general metabolic reactions, their
regional variations are not very pronounced.
1.5 General Characteristics of Neurotransmitter Transport
System
The term transport in this thesis refers to the mediated
translocation of neurotransmitters across a membrane barrier.
Uptake is regarded as inward transpot. As all neurotransmitter
transport systems are very similar and that the noradrenaline
transport system has been well-characterized, this system
will be discussed to illustrate the properties of neuro-
transmitter transport systems. These transport mechanisms
have been shown to be located at the plasma membrane of nerve
endings (Iversen, 1970). The membrane contains highly mobile
carriers that have an absolute Na+ requirement for their
activity and need a high Na concentration (0.1 M) for
maximal activation. The initial rates of uptake of 3H-NA has
been shown to follow Michaelis-Menten kinetics (Iversen, 1963).
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This finding supports the notion that trasmitter transport
is a carrier-mediated and saturable process. Additional evidence
for a carrier-mediated mechanism for neurotransmitter transport
is provided by the finding that amines structurally related
to NA can be transported and are competitive inhibitors of
NA transport (Horn et al., 197]). similarly, tryptamine is
a competitive inhibitor of the 5-hydroxytryptamine transport
system. Moreover, the neurotransmitter transport mechanism
is stereospecific for example, the NA system has higher affinity
for(-) 3H-NA than that for(+) 3H-NA (Hitzemann et al., 1975).
The finding that transmitter uptake processes are sensitive
to metabolic inhibitors indicates that transport processes
are energy dependent (Iversen, 1970). The energy dependence
will be discussed in the next section.
1.6 Ion Gradient Hypothesis for Transport of Amine Transmitters
The source of energy responsible for the uphill transport
of neurotransmitters is believed'to be derived from the ion
gradient as proposed by Crane (1965). The hypothesis is based
on the following observations (1) Amine transport is strongly
dependent upon the presence of extracellular Na+, (2) Sodium
and amine transport are directly related, i.e. both substrates
are transported togehter (cotransported). (3) Active
transport is dependent indirectly on Na+-K+-ATPase activity.
Active transport is directly energized by the electrolyte
gradient which in turn depends upon the activity of this
enzyme. (4) Kinetic studies indicate that Na+ decreases the
15
apparent Km of the carrier for the substrate whereas the Vmax
is less affected (Colburn et al., 1968 Bogdanski et al.,
1970a),suggesting that Na+ increases the affinity between
carrier and substrate.
Experimental evidence supporting this hypothesis has
been observed with the transport of NA (Bogdanski et al., 1968),
5-HT (Blackburn et al., 1967), choline (Schuberth and
Sundwal l, 1967) and DA (Coyle and Snyder, 1969) in various
brain preparations. The participation of Na+-K+-ATPase activity
in amine transport is indicated by the findings that both
transport and the enzyme require. not only Na+ but also K+
in low concentrations ranging between 1 and 25 mM and that
deficiency of K+ or high concentrations of K+ inhibit the
enzyme activity (Bogdanski et al., 1968). Moverover, ouabain,
a specific inhibitor of Na+-K+-ATPase, is inhibitory
(Bogdanski et al., 1968).
Also, the observation that NA increases the affinity of
the carrier for Na+ in synaptosomes suggests the occurrence of
cotransport (Bogdanski et al., 1970b),kinetic analysis shows
that amine and Na+ are transported stoichiometrically at a
1 to 1 ratio (Vidaver, 1964).
1.7 Release of Transmitters from Nerve Endings
Release of transmitter substances from presynaptic nerve
16
endings represents a fundamental step of chemical neuro-
transmission (Eccles, 1964 Krnjevic, 1974). In the brain, this
important event is physiologically- triggered by the nerve
impulse, is influenced by factors such as endogenous modulators
(Axelrod and Saavedra, 1974 Boulton, 1974) and changes in
the ionic environment (Blaustein, 1975) as well as under the
control of various pre- and post-synaptic homeostatic
mechanisms (Langer, 1974). Moreover, neurotransmitter release
is sensitive to neuroactive drugs and this also forms the
therapeutic basis of many neuroactive drugs (Blaustein, 1975
Sen et al., 1976 Colburn and Kopin, 1972).
Biogenic amine release from central nerve terminals has
been only partly characterized. However, the increasing
interest for central neurotransmission in recent years, and
the finding that various clinically active pharmacological
agents interfere with the release of monoamines in the
central nervous system have provided better understanding of
the mechanism of biogenic amine release. Some of the recent
advances in this area will be discussed below.
1.7.1 Intrasynaptosomal Biogenic Amine Transmitter Pools
Susceptible to Releasing Stimuli
It is general agreed that intraterminal biogenic amines
are largely bound or stored in synaptic vesicles and that, in
normal conditions, only low concentrations are present in a free
17
form in the cytoplasm (Whittaker, 1969). However, the
compartmentation of biogenic amines within the nerve terminals
is not limited to a vesicular and a cytoplasmic pool.
Evidence shows that the most recently synthesized pool of
biogenic amines has functional properties different from those
of the less recently synthesized amines it appears that the
newly synthesized amines are released preferentially in
experiments involving spontaneous as well as depolarization-
induced release (Besson et al., 1969 De Belleroche et al.,
1976 Kopin et al., 1968). This finding indicates that biogenic
amines in the nerve terminals can be separated into two
functional compartments-- one is preferentially released,
and the other is not.
Since biogenic amines present in nerve terminals are derived
not only from synthesis, but also from the reuptake of the
released amine, this raises the question which one of these
pools of amines is preferentially released upon stimulation. In
vitro studies indicate that the radioactive amines taken up
by nerve endings are rapidly bound to synaptic vesicles and that
the newly taken up amines are released unmetabolized from
synaptosomes when subjected to depolarizing stimuli (Mulder
et al., 1975 Raiteri et al., 1975). These findings suggest
that the amines taken up are preferentially released. Similar
process has been shown to occur in serotoninergic neurons
(McBride et al., 1976).
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Though much is known about the neurotransmitter bound
to synaptic vesicles, little is known about the functional
significance of the cytoplasmic pool of free biogenic amines.
Thus far, reports suggest that the cytoplasmic amine is not
involved in the depolarization release, and probably in
equilibrium with the vesicular pools. This equilibrium can
be altered in certain conditions, such as treatment with
reserpine or sympathomimetic amines, which cause vesicular
amine to become cytoplasmic (Colburn and Kopin, 1972 Axelrod
and Saavedra, 1974).
1.7.2 Mechanisms of Transmitter Release
The rate of biogenic amine release observed in physio-
logical media can be altered by changing the composition of
the bathing medium, e.g. ionic concentrations, addition of
drugs, or by applying electrical stimuli (Blaustein, 1975
Colburn and Kopin, 1972 D e Belleroche and Bradford, 1972).
In general, biogenic amines can either be transferred
extracellularly directly from synaptic vesicles or first be
released into the cytoplasm from the vesicles, and then
cross the plasma membrane, by simple diffusion or by carrier-
mediated transport.
The existence of exocytosis for NA and DA upon stimulation
has been shown to occur in nerve endings (Colburn et al., 1976
19
Fried and Blaustein, 1976 Mulder et al., 1975). Also, a
carrier-mediated release of noradrenaline has been reported
in reserpinized rabbit atria upon stimulation with sympatho-
mimetic amines (Paton, 1973).
1.7.2.1 Calcium-Dependent Release
Depolarizing stimuli induce a release of biogenic amines
from nerve endings which is strictly calcium dependent
(De Belleroche and Bradford, 1972 Blaustein et al., 1972
Blaustein, 1975). In fact, the influx of Ca++ accompanying
depolarization is considered to be the critical event
triggering neurotransmitter release (Katz and Miledi, 1970
Miledi, 1973). According to the calcium hypothesis, an
increased availability of free intracellular Ca++ is a
condition necessary and sufficient to elicit a release of the
neurotransmitter.
Depolarization of synaptosomes has been achieved by
electrical stimulation (De Belleroche et al., 1976) as well
as exposure to a solution containing high concentration of
potassium ions (Blaustein, 1975), and that this depolarization
process is accompanied by an increased influx of Ca++
(Blaustein, 1975). These findings suggest a direct transfer
from the synaptic vesicles to the extracellular space, possibly
by exocytosis (Raiteri et al., 1977).
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1.7.2.2 Release Induced by Alternations of the Sodium
Gradient
It has been shown that sodium deprivation stimulates
the release of 3H-NA, 3H-D A and 3H-5-HT (Raiteri et al.,
1977). In view of the dependence of the amine uptake on the
Na+ gradient across the nerve ending membrane (Bogdanski et al.,
1970a',it has been assumed that the increased efflux,
observed in the absence of extracellular Na+, is due to the
inversion of the Na+ gradient, which would favor an outward
transport of the amines. This assumption is in agreement with
the observation that desipramine and nomifensine, blockers
of amine transport, prevent 3H-NA and 3H-DA release induced
by Na+ deprivation (Raiteri et al., 1977). These results
suggest that cytoplasmic biogenic amines can exit from nerve
endings through specific carriers as this process is sensitive
to desipramine or nomifensine inhibition. Moreover, the amount
of amine exiting through the carrier depends on the avail-
ability of free amine in the cytoplasm which can be increased
by the combined threatment with reserpine and monoamine oxidase
inhibitor (Paton, 1973).
1.8 Interaction between Opiates and Biogenic Amine Transmitters
Considerable evidence has shown that changes of brain
5-HT and catecholamine synthesis and/ or metabolism were
observed after acute or chronic administration of morphine
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and other narcotic analgesics (Bowers and Kleber, 1971
Haubrich and Blake, 1973 Yarbrough et al., 1973 Goodlet
and Sugrue, 1974 Papeschi et al., 1975 Perez-Cruet et al.,
1975 Samanin et al., 1978). These results suggest that brain
5-HT and catecholamines might be involved in the pharmacological
activity of these compounds. This hypothesis is supported
by the fact that procedures affecting 5-hydroxytryptaminergic
and catecholaminergic mechanisms have been found to modify
the effect of narcotic analgesics in various animal species
(Samanin et al., 1970 Major and Pleuvry, 1971 Samanin and
Valzelli, 1971 Florez et al., 1972 Gorlitz and Frey, 1972
Genovese et al., 1973 Vogt, 1974 Garau et al., 1975
Sewell and.Spencer, 1975). Moreover, studies on the subcellular
localization of dihydromorphine have indicated that the
narcotics are mainly accumulated in the synaptosomal fraction
(Scarfani et al., 1969 Hug and Oka, 1969 Hug and Oka, 1971),
or nerve terminals. These findings suggest that the relation-
ship between the action of narcotic analgesics and brain
5-HT and catecholamines may be due to the ability of these
drugs to alter uptake or release of the neurotransmitters.
For instance, inhibition of 5-HT or catecholamine uptake by
these agents could result in an increased 5-HT or catecholamine
level in the vicinity of receptors involved with narcotic
analgesia.
1.9 Objectives of the Present Study
In view of the involvement of the 5-hydroxytryptaminergic
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and catecholaminergic mechanisms in the actions of opiates on
the central nervous system such as analgesia, the present
study was undertaken to investigate the effect of opiates
and, in particular, some opioid peptides on the reuptake and
release processes of the amine transmitters. The other putative
neurotransmitters such as y-aminobutyric acid, glutamic acid
and adenosine were also studied. It is hoped that through these
investigations, some of the possible sites of action of
opiate analgesics might be found. The rationale is based on
the fact that tricyclic anti-depressants exert their main
effect on the CNS by inhibiting the reuptake of biogenic
amines into presynaptic nerve endings.
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CHAPTER II MATERIALS AND METHODS
2.1 Materials
2.1..1 Chemicals
All chemicals used were of analytical grade. Methion1ne
enkephalin, leucine-enkephalin, puromycin dihydrochloride,
5-hydroxytryptamine hydrochloride, noradrenaline, dopamine,
sodium glutamate, adenosine, valine, tyrosine, histidine, leucine,
lysine, proline, tryptophan, choline chloride, dodecyl sodium
sulfate (SDS), crystallized bovine serum albumin, Folin and
Ciocalteu's phenol reagent, ouabain-8-hydrate (strophanthin-G),
2, 5-diphenyloxazole (PPO), Triton X-100 (octyl phenoxyl poly-
ethoxyethanol), adenosine-5'-triphosphate (ATP) were purchased
from Sigma Chemical Company, St. Louis, Missouri, U.S.A.
Potassium chloride, y-aminobutyric acid (GABA), magnesium
sulfate-7-hydrate, calcium chloride-2-hydrate, sodium dihydrogen
phosphate-2-hydrate, potassium hydroxide, potassium dihydrogen
phosphate, potassium sodium tartrate-4-hydrate, 2,2'-p-phenylene-
bis (5-phenyloxazole) (POPOP), di-potassium hydrogen phosphate,
sulfuric acid (95-97%), imidazole, hydrochloric acid (32%) were
purchased from Merck, Dr. Theodor Schuchardt Co., Hohenbrun,
Germany. Dextrorphan was from Roche, Nutley, New Jersey, U.S.A.
Methadone hydrochloride, morphine hydrochloride, pargyline
hydrochloride, glucose, sodium carbonate, cupric sulfate,
magnesium chloride-6-hydrate, ferrous sulfate-7-hydrate, ammonium
molybdate-4-hydrate, perchloric acid (71-73%) were purchased
from BDH Chemical Ltd., Poole, England. Sucrose, sodium chloride
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sodium hydroxide were purchased from Mallinckrodt Inc., Paris,
Kentucky, U.S.A. Toluene was from Ajax Chemical division of
Searle Australia Pty. Ltd., Auburn, Australia.
Levallorphan tartrate was kindly supplied by Dr. John Wong,
Department of Pharmacology, The Chinese University of Hong Kong,
Hong Kong. Naloxone hydrochloride was a generous gift from the
Endo Laboratory, Garden City, New Jersey, U.S.A.
2.1.2 Radioactive Compounds
3H-5-hydroxytryptamine binoxalate (26.4 Ci/mmol),
3H-noradrenaline (2.7 Ci /mmol), 3H-dopamine (26.9 Ci /mmol),
ine (26.9 Ci/mmol),3H-Y-aminobutyric acid (25.0 Ci/mmol), 3 H-prol
3H-adenosine (16.3 Ci /mmol), 3H-valine (56.8 Ci/mmol), 3H-lysine
(68.0 Ci /mmol), 3H-histidine (10.0 Ci /mmol), 3H-tyrosine
(53.3 Ci/mmol) were purchased from New England Nuclear, Boston,
Massachusetts, U.S.A. 14C-glutamic acid (285 mCi/mmol),
3H-leuc ine (65.0 Ci /mmol), 3H-tryptophan (28.5 Ci /mmol), 3H-
5-hydroxytryptamine creatinine sulphate (12.3 Ci/mmol) were
obtained from the Radiochemical Centre, Amersham, England.
2.2 Methods
2.2.1 Animals
Male Sprague Dawley rats weighing 200 to 250 g, kept in
a temperature controlled room (21°C) with free access to water
and food, were used in these experiments.
2.2.2 Preparation of Synaptosomes
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Animals were killed by decapitation. The brains were
quickly removed, weighed, and homogenized in 10 volumes of ice-
chilled 0.32 M sucrose in a glass homogenizer (Thomas type B)
with teflon pestle, using 10 up and down strokes.
Synaptosomes were obtained as described by Gray and
Whittaker (1962). The homogenate was centrifuged in a Sorvall
RC-5 super speed refrigerated centrifuge at 1,000 x g for 10
minutes at 4°C. The pellet (P1), composed of nuclei and cell
debris, was discarded. The supernatant was centrifuged at
15,000 x g for 20 minutes at 4°C to yield the crude mitochondrial
pellet (P2) which contained synaptosomes used in the uptake
studies.
2.2.3 Uptake Study of Radioactive Neurotransmitters in
Synaptosomes
The crude mitochondrial fraction (P2) was resuspended in
Kreb's Ringer phosphate buffer, pH 7.4 containing, in final
concentrations (mM): NaCl, 144.6 KC1, 5.80 MgSO4, 1.43
CaCl21 1.53 glucose, 10.0 NaH2PO4, 10.0. Samples of 0.5 ml,
containing 0.4 to 0.7 mg synaptosomal protein, were incubated
with 100 pl radioactive neurotransmitter at 25°C in a water
bath with or without drugs in a final volume of 1 ml. Pargyline
(15 ijM) was included to inhibit the action of monoam.ine oxidase
on the uptake study of monoamine neurotransmitters such as
5-hydroxytryptamine (5-HT) noradrenaline (NA) and dopamine
(DA). To account for the diffusion through membranes and non-
specific binding, some samples were incubated in a similar
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condition, but at 0°C. The difference between radioactive
neurotransmitter accumulated at 25°C and Q°C was then taken
as a measure of the active transport system. The reaction
was stopped by centrifuging the sample mixture in a micro-
centrifuge (Eppendorf) at 12,000 rpm for 1 minute. The supernatant
was removed by a pasteur pipette, and the sample was further
centrifuged for another 0.5 minute to remove the liquid adhering
to the sides of the microcentrifuge tubes. The pellet was
dissolved-,in 0.5 ml 10% SDS. After 24 h an aliquot of 0.2 ml
was transferred to a counting vial, and 7 ml scintillation
cocktail (0.4% PPO, 0.04% POPOP, 2 vol. toluene, 1 vol Triton
X-loo) were added, Radioactivity was determined in a Beckman
LS-7000 liquid scintillation counter. Counting efficiency was




2.2.4 Release Study of Radioactive Neurotransmitters in
Synaptosomes
Synaptosomes were preloaded with radioactive neurotran-
smitter at 25°C in Kreb's Ringer phosphate buffer. Uptake was
stopped by cooling in ice-cold water. The suspe~sion was
divided into 2 portions and centrifuged at 15,000 x g for 10
minutes at 4°C. One synaptosomal pellet was resuspended in
normal Kreb's Ringer phosphate buffer that was used in uptake
studies. The other pellet was resuspended in a modified Kreb's
Ringer phosphate buffer in which NaCl was replaced by equal
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concentration of choline chloride, and sodium phosphate buffer
was substituted by potassium phosphate buffer. In effect this
medium is Na+-free. Aliquots of 0.2 ml of the preloaded synap-
tosomes were incubated at 25°C for 1 minute to allow equilibration
after which drugs and Kreb's Ringer phosphate buffer were added
to give a protein concentration of 0.1 mg/ml. Samples lacking Na+
were loaded with KC1 to give a final concentration of 56 mM.
Release incubation was terminated by centrifugation as described
in section 2.2.3 of this chapter. The pellet was dissolved in 0.5 ml
10% SDS. Aliquots of 0.3 ml were counted as described in the previous
section.
Percentage stimulation of release induced by drugs was
calculated by the formula:




2.2.5 Assay of Na+--K+-ATPase Activity in Synaptosomes
The Na+-K+-ATPase activity was determined by the modified
method of Medzihradsky et al. (1971). The crude synaptosomal
fraction (P2) was suspended in imidazole-HC1 buffer (50 mM, pH 7.0).
The concentration of protein in this assay ranged from 0.07 to
0.09 mg/ml. To four sets of tubes, 0.4 ml of P2 suspension was
added. One set received 40 p1 ouabain in final concentration of
0.4 mM. Another set received 40 pl drug but no ouabain while the
third set received both ouabain and drug. The set containing neither
ouabain nor drug gives the total ATPase activity. The set containing ouabain provides
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the non-Na+-K+-ATPase activity. Thus, the difference in ATP-
hydrolyzing activity between the former and the latter sets
gives the Na+-K+-ATPase activity. All tubes, kept in ice, were
adjusted with incubation medium to give a final concentration
(mM) of: NaCl, 90 KC11 20 MgCl2, 3 and imidazole buffer
(pH 7.0), 50. The samples were pre-incubated for 10 minutes
at 37°C to deplete the endogeneous ATP. After pre-incubation,
40 pl ATP was added to yield a final concentration of 3 mM.
Samples were incubated at 37°C for 40 minutes in a shaking
water-bath reaction was terminated by the addition of 0.4 ml
of ice-cold HC1O 4 (1.2 M). Blanks were prepared by adding 0.4
ml of HC1O 4 (1.2 M) before the addition of ATP. After centri-
fugation in an Eppendorf microcentrifuge for 2 minutes, aliquots
of 1 ml protein-free supernatant were transferred into tubes
in which 1 ml of a freshly prepared solution of 144 mM ferrous
sulfate in 8.15 mM ammonium molybdate and 0.58 mM sulfuric
acid was added. After standing for 5 minutes at room temperature,
the samples were read at 700 nm against buffer blanks. Inorganic
phosphate in the linear range of 8 to 80 pg of Pi (K2HPO4)
was used as standard. The rate of Pi liberated in the absence
of ouabain, corrected for the zero-time blanks, was the
total ATP-hydrolyzing activity. The Na+-K+-ATPase activity
was calculated by subtracting activity remaining in the
presence of ouabain (Mg++-ATPase) from the total activity.
The enzymatic activity of ATPase was expressed in terms of
pmoles of Pi liberated per mg protein per h.
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2.2.6 Protein Determination
Protein determination was assayed by a modification of
Lowry procedure as described by Markwell et al. (1978). The
method employs solubilization of membrane and lipoprotein
samples in SDS in the alkali reagent, which is convenient
and .time-saving as compared with overnight solubilization in
alkali and delipidation required by the original Lowry
procedure. Moreover, the increase in copper tartrate reagent
eliminates the interference induced by sucrose or EDTA.
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CHAPTER III EFFECT OF OPIATES ON THE TRANSPORT OF 5 -HYDROXY-
TRYPTAM INE IN RAT BRAIN S YNAPTOS OMES
3.1 Introduction
5-Hydroxytryptamine (5-HT) is involved in a number
of specific brain functions such as temperature regulation,
gonadotropin secretion, integration of pain perception, and
sleep mechanisms (Snyder, 1976). However, no firm and specific
conclusions can be reached about the contributions of
the 5-HT system, since the neural circuitory subserving
each of these functions is not well defined. It is proposed
that, in most target areas of 5-HT fiber projections, the
primary role of 5-HT is to dampen or inhibit neuronal activity
as suggested by numerous microelectrophoretic studies in
the neocortex, thalamus, hypothalamus, and limbic system
(Bloom et al., 1972).
As a neurotransmitter, 5-HT is released in the CNS both
under resting conditions and as a result of neuronal
activity. Ventricular perfusion experiments in anesthetized
cats showed a basal release of 5-HT from the caudate nucleus
and septal region. Electrical stimulation or high K+ medium
stimulates the calcium-dependent release of 5-HT from the
superfused slices of rat cerebral cortex, hippocampus and
hypothalamus preloaded with 3H-5HT (Tanaka and Tsujimoto,
1981).
31
There is convincing evidence that 5-HT released in
response to physiological stimuli is taken up into nerve
terminals associated with tryptaminergic neurons in
mammalian brain by an active, high affinity, saturable
uptake process (Kuhar, 1973). This process is very selective
and, if synaptosomes prepared from the forebrain of raphe-
lesioned animals are studied and proper concentrations of
putative neurotransmitters used, only the uptake of 5-HT
is affected, whereas the uptake of DA and NA is unchanged.
(Kuhar et al., 1972). The high affinity uptake of 5-HT
in tryptaminergic neurons is sodium-dependent and is inhibited
by various indolamines and by tricyclic antidepressant drugs
of both the imipramine and amitriptyline series, among which
3-chloroimipramine is the most potent inhibitor of 5-HT
uptake sites (Ki approx. 0. 1 pM).
Studies designed to assess the role of monoamines in
both the complex processes of integration of pain sensation
and mechanisms of analgetic action-of morphine suggest that
the neuronal system containing 5-HT as a putative transmitter
plays an important role. For instance, pretreatment with
the 5-HT synthesis inbibitor para-chlorophenylalaf.ine (PCPA)
reduced the analgesic effects of morphine in mice on the
hot plate (Major and Pleuvry, 1971) and in phenylquinone
tests (Fennessy and Lee, 1970), as well as in rats in the
flinch-jump (Tenen, 1968) and pawn-pinch test (Goolitz and
Frey, 1972). The decrease of brain 5-HT caused by a lesion
in the nucleus raphe medianus is accompanied by a reduction in
morphine analgesia.- Intraventricular injection of 5-HT
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enhanced morphine analgesia (Samanin et al., 1970).
Moreover, electrical stimulation of the nucleus raphe
medianus, which causes a release of 5-HT in the forebrain
(Aghajanian et al., 1967), markedly potentiates morphine
analgesia whereas pretreatment of the animals with PCPA
abolishes the effect of raphe stimulation. These findings
suggest that the analgesic action of morphine may be mediated
through 5-HT action. It would be of interest to investigate
whether alkaloid opiates and opioid peptides affect the
uptake and release processes of 5-HT as both processes
determine the level of 5-HT in the vicinity of the receptors
involved in analgesic action of opiates.
3.2 Uptake of 3 H-5HT
Brain synaptosomes showed a rapid, linear uptake of
3H-5HT during the first 5min. and a slower accumulation
rate for the following 30 min. (Fig. 3 .1). Methadone and
dextrorphan: at a concentration of 25 uM I strongly inhibited
the uptake of 3H-5HT throughout the incubation period.
The initial rate of uptake of 3H-5HT at 5 min. was 1.28
pmol /mg protein/ min for the control. Removal of Na+ or
addition of ouabain (0.4 mM) reduced the uptake of 5-HT
by 89% and 82%, respectively (Data not shown).
Fig. 3.2 shows the Lineweaver-Burk plot of 3H -5HT
uptake in the presence and absence of opiates. The control
showed the biphasic nature of 3H-5HT uptake, having a high
Fig. 3,1 Time course of H-5HT uptake into rat brain
synaotosor.es. Samples of 0.5 ml (0.1 to 0.7 mg
orotein) of rat brain synaptosomes were incubated
at 25°C with 10 M 'H-5HT with or without drug
added for different periods of time. Results are
expressed as mean t- S.D. of three separate
exoeriments in triplicate. The standard deviations
are less than k%. represents control H-5HT













Lineweaver-Burk plot of 3H-5HT uptake into rat brainFigo 3.2
synaptosomes. Plotted are the reciprocal initial
concentrations of 5-HT in the medium against the
reciprocal rates of5-HT uptake. Methadone( ) and
dextrorphan ( ) changed the value of Km for the
5-HT transport as compared with the control( ).
In. the control, two uptake systems were observed:
the high affinity and the low affinity. The values
for these kinetic parameters are listed in Table 3.1
Presented are mean values of triplicate experiments.
1/[5HT] <1/M>
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affinity uptake system-with Km of 9x10 °M and a low-affinity
uptake system with Km of 2.5x10-6M. Both methadone and
dextrorphan inhibited the high affinity 3H-5HT uptake in
a competitive manner. These drugs decreased the affinity
of the substrate 5-HT to the transport carrier, resulting
in. an increase in the Km of the substrate. On the other
hand, methadone and dextrorphan did not change the Vmax
of the 5-HT uptake process (Fig. 3.2, Table 3.1).
3.3 Effect of Active and Inactive Opiates on the Uptake
of 3H-5HT
Fig. 3.3 shows the inhibition effects of various drugs
at 25 pM on the uptake of 3H-5HT into brain synaptosomes.
Methadone was the most active compound and it caused 83.5%
inhibition while dextrorphan, the (+)-isomer of levorphanol,
which is an inactive opiate, showed less inhibition (72.2%).
Other opiates and endogenous opioid peptides such as morphine
and met- and leu-enkephalin showed much less activity,
being 20, 21 and 16%, respectively. The narcotic antagonist
.naloxone exhibited similar activity as morphine. However, the
antagonist levallorphan showed somewhat a higher activity
(39.4%) than na loxone.
3.4 Inhibition of Uptake of 3H-5HT by Methadone and Dextrorphan
As methadone and dextrorphan markedly inhibited the
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Table 3.1 Inhibition of 3H-5HT Uptake in Rat Brain Synaptosomes
by Methadone and Dextrorphan
Hih Affinity Uptake Low Affinity Uptake
Drug Km (UM) Vmax(pmol/mq protein/min) Ki (iM) Km (UM) Vmax(pmol/mq prot/min)
None 0.09 2.50 2.50 13.33
Methadone 0.77 2.50 8.0
(25uM)
Dextrorphan 0.63 2.50 19.0
(25pM)
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Effect of opiates on H-5HT uptake into rat brainFig. 303
synaptosomes. 3H-5HT (10-7M) was incubated with
synaptosomes in Kreb's Ringer phosphate buffer, with
or without opiate drug (2.5 x 10-5 M) for 40 min at
25°C with shaking. Reaction was terminated by
centrifugation and samples dissolved and counted as
described in. Methods. Inhibition of 3H-5HT uptake















uptake of 3H-5HT into synaptosomes, the effect of these
two drugs on 5-HT uptake at various concentrations was
investigated. Methadone at 10-8 M caused an inhibition effect
of 29.5% and the complete inhibition of 3H-5HT uptake was
achieved at 10-4 M and the IC 50 of methadone was l.70x10-7 M
(Fig. 3.4). Dextrorphan was less active than methadone with
an IC 50 of 2.14x10-6 M. The dose-response curve of Dextrorphan
(Fig. 3.4) showed its inhibition ability of uptake of 3H-5HT
approached that of methadone at higher concentrations with
a nearly complete inhibition at 10-4 M (91.4%).
The inhibition constants Ki of methadone and dextrorphan
were determined by the Dixon plots of the uptake of 3H-5HT
in the presence of the drugs (Fig. 3.5, Fig. 3.6). Plotted
are the reciprocal rates of 3H-5HT uptake against the
concentrations of inhibitor in the medium. Three concentrations
of 5HT were used: 5xl0-8 M, 10-7 M and 2x10-7M. Ki values
of methadone and dextrorphan were found to be 8 pM and 19 uM
respectively, (Table 3. 1).
In order to test if methadone and dextrorphan inhibit
5HT uptake by acting on the same site or by the same
mechanism, the effect of sub-maximal dose of methadone and
dextrorphan on this neurotransmitter uptake was studied.
Table 3.2 shows that addition of 1 uM of methadone
plus 1 uM of dextrorphan caused a 73.4% inhibition while
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Fig. 3.4 Log dose response for inhibition of 3H-5HT uptake
into rat brain synaptosomes by methadone and
dextrorphan. The concentration range from 10-8 M to
l0-4 M was tested-for methadone( 0) and dextrorphan
( ). Each point represents the mean of three
experiments performed in triplicate. Standard deviations
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Fig c 3,5 Dixon plot for the determination of the inhibition
constant of methadone for H-5HT uptake into rat
brain synaptosomes. Plotted are the reciprocal rates
of H-5HT uptake against concentrations of the
inhibitor methadone. The inhibition constant Ki is
determined from the point of intersection of three
lines, each describing the uptake process at
different concentrations of 5-HTe
of 5-HT„
Mathadone
Fie. 3.6 Dixon plot for the determination of the inhibition
constant of dextrorphan for H-5HT uptake into rat
brain synaptosomes. Plotted are the reciprocal rates
of H-5HT uptake against concentrations of the
inhibitor dextrorphan. The inhibition constant Ki
is determined from the point of intersection of
three lines, each describing the uptake process
at different concentrations of 5-HTe at
M and at
Daxtrorphan <M>
Table 3.2 Similar Interaction Sites of Methadone and
Dextrorphan Associated with the Inhibitory
Action on H-5HT Uptake
Drug Inhibition of Uptake of H-5HT(%)
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methadone (1 tM) alone and dextrorphan (1 pM) caused 64.6
and 40.2% respectively. This finding suggests that the
interaction sites of methadone and dextrorphan with the
synaptosomal membrane are possibly similar. Binding of one
drug may affect the binding affinity of the other. In fact,
the- addition of 25 pM dextrorphan did not increase the
inhibitory activity of 25pM methadone( 25 pM methadone
plus 25 pM dextrorphan, 82.6% inhibition 25pM methadone,
82.2% inhibition)
3.5 Inability of Naloxone to Alter the Effectiveness of
Methadone to Inhibit Uptake of 3H-5HT
Results in the previous sections show that both active
and inactive opiates are active in reducing the uptake of
5-HT. In order to understand better if these drugs may exert
their effect by interacting with opiate receptors, the effect
of naloxone,an opiate antagonist, on the inhibitory action
of methadone was investigated.
As shown in Fig. 3.7, naloxone was unable to reverse
the inhibitory action of methadone on 3H-5HT uptake. Various
concentrations of methadone were tested naloxone at five
times the concentration of methadone failed to antagonize the
action. In agreement with the previous result (Fig. 3.3), that
naloxone alone caused an inhibitory effect, the addition of
this antagonist caused a small reduction in 5HT uptake in
all situations.
50
Fig, 3.7 Inability of naloxone to alter methadone inhibition
of 3H-5HT uptake into rat brain synaptosomes.
Different concentrations of methadone (shaded bars)-
were tested, and naloxone at five times the concent-
ration of methadone, represented by dotted bars, was
added. The control without methadone added is denoted
by the blank bar.
Methadone
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3.6 Effect of Opiates on the Release of 3H-5HT from
Synaptosomes
Results presented in the previous sections clearly
suggest that methadone markedly inhibited the uptake of 5-HT,
as it is possible that the inhibition observed may be due to
the action of opiates on the release of this neurotransmitter
thus the effect of various opiates on 5-HT release was studied.
Efflux of 3H-5HT from preloaded synaptosomes was studied
under two conditions: spontaneous release,Na+-free plus
K+-stimulated release as it has been shown that KC1 at a
concentration of 56 mM evoked a calcium-dependent exocytotic
release (Blaustein, 1975), while Na+-depleted medium evoked
a carrier-mediated release (Raiteri et al., 1977). To prevent
the reuptake of the amine released, this study was carried
out (a) in the absence of extracellular Na+, as the inversion
of the Na+ gradient favors a carrier-mediated outward
transport of the amine, and (b) low synaptosomal protein
concentration (0.1 mg/ml) used in all release experiments.
Furthermore, effect of drugs on release was observed during
the initial release rate, i.e. the first 5 min.
Fig. 3.8 shows the release time-course of H-5HT.
Spontaneous release amounted to 18% of the total in the charged
synaptosomes in 5 min. The rate of Na+-free plus K+-stimulated
release of 3H-5HT was greater, with a value of 58% of the
total in the first 5 min. As the release was almost complete
Fig 3= 8 Time course of H-5HT release from rat brain
synaptosomes: represents spontaneous release
of 3H-5HT, denotes K+-induced release of 1-5HT
in Na -free medium Release of H-5HT was effected
by incubating preloaded synaptosomes for different
periods of time Relative amount of H-5HT released




at 5 min, thus the jH-5HT release from 0 to 5 min was observed.
Table 3.3 shows the effect of narcotic drugs on the release
of 3H-5HT from brain synaptosomes. For spontaneous release
study, none of the narcotics or antagonists significantly
increased the release of 3H-5HT. However, the effect of drugs
was more obviously seen in Na+-free, K+-stimulated release of
3H-5HT. Methadone, naloxone, levallorphan, met-enkephalin
and leu-enkephalin showed slight but significant stimulatory
effect on 3H-5HT release. It should be noted that the
stimulatory action of the two opioid peptides were greater
than the alkaloid opiates. Dextrorphan and morphine had no
3
effect on H-5HT release.
3.7 Discussion
Synaptosomes were used in the present study to investigatE
the effect of opiates relating to the uptake and release
processes of 5-HT in the synaptic region.
Uptake of 5-HT into rat brain synaptosomes.is carrier-
mediated with two transport systems: high affinity and low
affinity. The high affinity transport system possesses a
Km value of appoximately 10-7 M and Vmax of 2.50 pmol/mg
protein /min, while the corresponding values for the low-
6
affinity uptake are 2.5x10- M and 13.33 pmol/mg protein/min.
Among the various opiate agonists, antagonists and opioid
peptides tested, methadone and dextrorphan were most potent
Table 3.3 Effect of Opiates on the Release of H-5HT
from Rat Brain Synaptosomes
Stimulation of Release of H-5HT(%)
Drug (25yM) Spontaneous Releasec InducedRelease3
Release in physiological medium
Release in high K and Na -free medium









in inhibiting the uptake of 5-HT into synaptosomes with IC50
values of 1.70x10-7 M and 2.14xl0-6 M respectively, and Ki
values determined by Dixon plots to be 8x10-6 M and 1.9x10-5 M
respectively. On the contrary, morphine and naloxone were
weak inhibitors of 5-HT uptake with Ki values extending into
the millimolar range (Cahill and Medzihrodsky, 1976). Since
dextrorphan, an inactive isomer of the opiate agonist
levorphanol, is a quite potent uptake inhibitor of 5-HT, and
that it has practically no opioid activity in intact animals
(Goldstein and Sheehan, 1969), it seems that the inhibition
of 5-HT uptake is not related to the pharmacological effects
of opiates. Moreover, morphine and the two antagonists naloxone
and levallorphan all inhibited uptake of 5-HT slightly.
Similarly, the endogenous opioid peptides met-enkephalin and
leu'-enkephalin are also weak inhibitors of 5-HT uptake.
The fact that naloxone did not antagonize the inhibitory
action of methadone on 5-HT uptake and that methadone inhibite(
competitively 5-HT uptake while morphine inhibited 5-HT uptake
in a non-competitive manner (Nennini et al., 1978) suggests
that the interaction of methadone with the uptake of 5-HT
does not involve the opiate receptor and that methadone
and morphine affected 5-HT uptake in the pre-synaptic nerve
terminal by two different mechanisms.
Methadone and dextrorphan are the two most potent inhibitors
of 3 H-5HT uptake in rat brain synaptosomes. Their inhibitory
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action is competitive, as the affinity between 5-HT and the
transport carrier or the Km value was increased. However,
Vmax values in both cases were not affected. They showed
dose-response on inhibition of 3H-5HT uptake in the range
from 10-8 M to 10-4 M. However, methadone and dextrorphan
probably bind to similar sites on the carrier of the nerve
terminal since lpM methadone and lpM dextrorphan did not show
additional inhibition effect. Indeed, addition of 25jiM
dextrorphan did not enhance the inhibitory effect of 25pM
methadone.
Since transport of 5-HT at the pre-synaptic nerve terminal
is bidirectional, an uptake-inhibitor of 5-HT may affect the
release process of 5-HT. However, it was observed that of all
the opiate agonists, antagonists and opioid peptides tested,
none significantly affected the spontaneous release of
preloaded 3H-5HT. Induced release of 3H-5HT by high K+
concentration and Na+-free medium slightly stimulated by
methadone (11.2%), naloxone (14.8%), levallorphan (14.3 0) and
the opioid peptides met-enkephalin (25.2%) and leu-enkephalin
(17.9%). This finding suggests that certain opiates
particularly the two opioid peptides, inhibited the 5-HT
uptake, by stimulating the efflux of this neurotransmitter,
while others, like methadone and dextrorphan inhibited the
uptake by lowering the affinity of the carrier for 5-HT.
In conclusion, it seems that the action of morphine and
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other opiates on the transport of 5-HT may not be a primary
site of action of*analgesics. However, opiates may regulate
the level of 5HT in the vicinity of the receptors by inhibiting
its re-uptake. As to relationship between analgesic action
and tryptaminergic neurotransmission, it has been proposed
that the analgesic action of morphine partially depends on
its blocking action on central 5-HT receptors (Gaddum and
Vogt, 1956). This concept is supported by studies on peripheral
5-HT receptors using the isolated guinea pig ileum where 5-HT
is believed to initiate peristaltic reflexes (Marczynski and
Vetulani, 1961). In addition, several investigators found
that there is a parallel relationship between analgesic
potency and 5-HT antagonizing activity (Gyand et al., 1964
Kosterlitz and Lees, 1964).
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CHAPTER IV EFFECT OF OPIATES ON THE TRANSPORT OF CATECHOLAMINES
IN RAT BRAIN S YNAPTOS OMES
4.1 Introduction
The catecholamine neurotransmitters, noradrenaline (NA)
and dopamine (DA) occur in specific neuronal systems in.
different areas of the brain (Fuxe, 1965 a, b). High affinity
uptake systems for catecholamines has been described in the
brain (Snyder et al., 1968a) and may serve to terminate actions
of catecholamines at central synapses. In the brain, it has
been possible to demonstrate this uptak.e system in vitro in
slices (Snyder et al., 1968b), in isolated synaptosomes
(Davis et al., 1967) and in homogenates (Snyder and Coyle, 1969).
Release of catecholamines from depolarized synaptosomes has
been observed by electrical stimulation (De Belleroche,1976)
and by high concentrations of potassium ions (Blaustein et al.,
1976 Mulder et al., 1975). Both catecholamine uptake and
release processes were found to be calcium-dependent.
There is evidence that catecholamines in the central
nervous system interact with morphine and other narcotic
analgesic drugs. For instance, acute administration of morphine
to animals caused depletion of dopamine from the striatum
(Gunne et al., 1969) and noradrenaline from the hypothalamus
(Reis et al.,1969). Administration of an analgesic dose
(10 mg/kg, s.c.) of morphine increased the concentrations of
the dopamine metabolites, 3,4-dihydroxyphenylacetic acid (D OPAL)
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and homovanillic acid .(HVA) in the brains of normal mice,
and that the time course of the change in the DOPAC concentration
corresponded approximately to that of morphine analgesia. The
present study was under-taken to study whether narcotic drugs,
including the opioid peptides, have a direct action on the
processes of uptake and release of catecholamines in nerve
terminals.
4.2 Effect of Methadone and Dextrorphan on the Uptake of
3H-NA and 3H-DA
Figs. 4.1 and 4.2 show the time courses of the uptake of
3 3
H-NA and H-DA in rat brain synaptosomes at substrate
concentration of 10-7 M. Uptake of 3H-NA was saturated at
40 min, while that of 3H-D A at 30 .in. The amounts of NA and
DA accumulated at these times were 18.85 pmol/mg protein and
11.51 pmol/mg protein, respectively. Methadone and dextrorphan
at 25 PM exerted a strong inhibitory effect on the uptake of
these two catecholamines throughout the course of incubation.
Moreover, methadone, an active opiate, was much more effective
than dextrorphan, the inactive opiate (Figs. 4.1 and 4.2).
Figs. 4.3 and 4.4 show the Lineweaver-Burk plots of
the uptake kinetics of 3H-NA and 3H-D A in the presence of
dextrorphan or methadone, both at 25 pM. It may be observed
that transport of 3H-NA was mediated by a high-affinity uptake
system with a Km of 0.19 uM and Vmax of 3.08 pmol/mg protein/min
Fie. 4.1
3
Time course of H-NA uptake into rat brain synaptosomes.
H-NA (10 M) was incubated with synaptosomes, with
t
or without drug added, for different periods of time.
Results are expressed as mean!: S.D. of three
separate experiments in triplicate. Standard deviations
are less than 1%. denotes control,
represents inhibition by M dextrorphan,
shows inhibition by M methadone.
TIME <min>
Fig 42 Time course of H-DA uptake into rat brain synapto-
somes. H-DA (10 M) was incubated with synaptosomes
with or without drug added for different periods of
time Results are expressed as mean- S.D. of
three sepa.rs.te experiments in triplicate. Standard
deviations are less than L% denotes control,
represents inhibition by
dextrorphan, shows inhibition by
methadone.
Time <min>
Lineweaver-Burk plot of H-NA uptake into rat brain
synaotosomes, Plotted are the reciprocal initial
concentrations of NA' in the medium against the
reciprocal rates of NA uptake, Methadone and
d extr orphan changed the value of Km for the
NA transport as compared with the control The
obtained values of Km and Vmax are listed in fable 1.1
Presented are mean values of triplicate experiments.
Fig. 4.3
1/[NA] 1/M
Fig. 4.4 Lineweaver-Burk plot of H-DA uptake into rat brain
synaptosomes Plotted are the reciprocal initial
concentrations of DA in the medium against the
reciprocal rates of DA uptake. Methadone and
dextrorphan changed the values of Km for the DA
transport as compared with the control The
obtained values for Km and Vmax are listed in Table
4.2. Presented are mean values of triplicate experiments.
1V mg prot minpmo!
1 DA <1/uM>
(Fig. 4.3 and Table 4.1). Similarly, the Km and Vmax values
for the H-DA transport were 0.2 y M and 3.0 pmolmg protein
min (Fig. 4.4 and Table 4.2). Methadone and dextrorphan
inhibited the uptake of H-NA and H-DA in a competitive
manner. These drugs diminished the affinities of NA and DA
for their respective transport carriers, while the Vmax values
of these two systems were unaffected (Tables 4.1 and 4.2, Figs.
4.3 and 4.4).
4.3 Effect of Opiates on the Uptake of H-NA and H-DA
Since both methadone and dextrorphan inhibited the uptake
of both catecholamines into synaptosomes, the effect of other
opiates were also investigated. Fig. 4.5 shows the inhibitory
action of various opioid drugs (all at 25 yM) on the uptake
of H-NA in brain synaptosomes. The drugs may be divided into
two groups according to their inhibition potency. Methadone,
dextrorphan and levallorphan belonged to the group that had
greatest inhibitory action on the uptake of H-NA. The opioid
peptides (met-enk and leu-enk), and naloxone had smaller but
significant inhibitory effect. Like the effect on NA uptake,
all active and inactive opiates tested, lowered the uptake of
DA (Fig. 4.6). However, the inhibitory effect was different:
methadone being most potent, the inhibitory effects of
dextrorphan, levallorphan and the two opioid peptides ranged
from 25 to 35% and those of morphine and naloxone were lower
than 15%.
71
Table 4.1 Inhibition of 3H-NA Uptake in Rat Brain
Synaptosomes by Methadone and Dextrorphan
High Affinity Uptake
Drug Km (pM) Ki (pM)Vmax(pmol/mg protein/min)
None 0.19 3.08
0.83 3.08 12Methadone (25 UM)
Dextrorphan 0.63 3.08 50
(25pM)
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Table 4.2 Inhibition of 3H-DA Uptake in Rat Brain
Synaptosome by Methadone and Dextrorphan
High Affinity Uptake
Drug Km (pM) Ki (UM)Vmax(pmol/mg protein/min)
0.20None 3.0
0.63 3.0 28.8Methadone (2 5 pM)
0.45 3.0 46.0Dextrorphan (2 5 UM)
Fig:4:5 Effect of opiates on 'H-NA uptake into rat brain
synaptosomes. 'TI-NA (10 M) was added to synapto-
somes and incubated' with various ooiate drug-s CJ
(2«5 x 10 M) for 10 min at 2f°C, as described in
Methods,other details can be found in text.
3
Inhibition of H-NA uptake by opiates is expressed as
perecnt of control uptake.





Fig; 4.s6 Effect of opiates on H-DA uptake into rat brain
synaptosomes. H-DA at concentration of 10 M was
added to synaptosomal preparation and incubated with
various opiate drugs (2.5 x 105 M) for 30 rain at
25°C. Inhibition of 'H-DA uptake by opiates is
expressed as percent of control uptake.
4.4 Inhibition of Uptake of H-NA and H-DA by Methadone
and Dextrorphan
Fig. 4.7 shows that methadone and dextrorphan inhibited
the uptake of H-NA in synaptosomes in a dose-dependent manner.
At concentrations below 10 M, the inhibitory potency of
dextrorphan on H-NA uptake was greater than that of methadone.
However, the opposite was true at higher concentrations of the
added drug. For example at 10 M of the added drug, the
inhibition of H-NA uptake by methadone and dextrorphan was
83.7% and 72.1% respectively. The values for methadone
and dextrorphan on H-NA uptake were 1.5 x 10 M and 2.00 x
10-5 M.
From the dose-response curves of drug inhibition on
uptake of H-DA in synaptosomes (Fig. 4.8), it can be observed
that at concentrations below 10 M of the added drug, the
inhibition effect of dextrorphan was greater than that of
methadone; however, above this concentration, methadone was
more effective than dextrorphan. The ICq values of methadone
and dextrorphan on H-DA uptake were 2.66 x 10 M and
5.62 x 10 M respectively.
Figs. 4.9 and 4.10 show the Dixon plots for finding the
inhibition constants Ki of methadone and dextrorphan for the
uptake of H-NA. Reciprocal rates of H-NA uptake were plotted
against the concentrations of the inhibitor in the incubation
Fig. 1.7
3
Log dose response for inhibition of H-NA uptake
into rat brain synaptosomes by methadone and
dextrorphan, The dosage from M was
tested for methadone and dextrorphan
Each point represents the mean of three separate
experiments performed in triplicate. Standard
deviations are less than 1%.
— Loo Cone of Drug (M)
Fig, 48 Log dose response for inhibition of ~H~DA uptake
into rat brain synaptosomes by methadone and
dextrorphan. The dosage from 10 M to 10 M was
tested for methadone and dextrorphan
Each point represents the mean of three separate
experiments performed in triplicate. Standard
deviations are less than L%.
? ~ ~ ~ ~ —
Fi p-- a 9 Dixon plot for the determination of the inhibition'j.
3
constant of methadone for H-NA uptake into rat brain
synaptosomes, Plotted are the reciprocal rates of
3
H-NA uptake against concentrations of the inhibitor
methadone• The inhibition constant Ki is determined
from the point of intersection of three lines, each
describing the uptake process at different concentrations
of NA„ at M of NA, at
and at
rng prct: rn in prno5
iVisthadonG uTm1 f
Fig. 110 Dixon plot for the determination of the inhibition
constant of dextrorphan for H-NA uptake into rat
brain synaptosomes. Plotted are the reciprocal rates
of H-NA uptake against concentrations of the inhibitor
dextrorphan, The inhibition constant Ki is determined
from the point of intersection of three lines each
describing'the uptake process at different concent¬
rations of NA, at
and at
Dextrorphan 〈μΜ〉
medium. Three concentrations of NA were used: 5 x 10 M,
10 M and 2 x 10 M. The inhibition constants Ki of
methadone and dextrorphan were determined to be 12 y M and
50 y M respectively (Table 4.1). The Dixon plots of Figs. 4.11
and 4.12 indicate that the inhibition constants of methadone
and dextrorphan for H-DA uptake were found to be 28.8 yM and
46.0 yM (Table 4.2).
Table 4.3, shows that the inhibitory effect on the
H-NA uptake of 1 yM methadone plus 1 yM dextrorphan (54.3%)
was approximately equal to the sum of the inhibitory effects
of 1 y M methadone alone (28.5%) and 1 yM dextrorphan alone
(30.7%). However, the inhibitory ability by 25 yM methadone
plus 25 yM dextrorphan which caused 75.8% inhibition was
smaller than the sum of inhibition caused by 25 yM methadone
(60.2%) and 25 yM dextrorphan (47.4%). Together with the fact
that both methadone and dextrorphan competitively inhibit
the uptake of H-NA, these findings suggest that both methadone
and dextrorphan affect the uptake of H-NA by interacting
with similar or closely related sites.
In the case of the uptake process of H-DA (Table 4.4)
the inhibitory potency of 25 yM methadone plus 25 yM dextrorphar
(68.6%) was smaller than the sum of inhibition caused by
25 yM methadone alone (56.1%) and 25 yM dextrorphan alone
(40.2%). Similarly, inhibition caused by methadone (1 yM) plus
dextrorphan (1 yM) was less than the sum of inhibition caused
h1 u (y j ~i J Dixon plot for the determination of the inhibitionA.
constant of methadone for H-DA uptake into rat
brain svnaotosomes. Plotted are the reciprocal rates
of u-DA uptake against concentrations of the
inhibitor methadone, The inhibition constant Ki is
determined from the point of interaction of three
4
lines, each describing the uptake process at
different concentrations of DA.
1£ m g prat: minpmol
-3Q— SO -10 Q 1Q SO 30
Fig. 1,12 Dixon plot for the determination of inhibition constant
of dextrorphan for 'H-DA uptake into rat brain
synaptosomes. Plotted are the reciprocal rates of
'H-DA untake against concentrations of the inhibitor
dextrorphan» The inhibition constant Ki is determined
from the point of intersection of three lines,
each describing the untake process at different
concentrations of DA.
M a.nd
1v m g prot minpmol
Oextrorphan O M
Table 4.3 Similar Interaction Sites of Methadone and
Dextrorphan Associated with the Inhibitory
Action on H-NA Uptake















Table 4.4 Similar Interaction Sites of Methadone and
Dextrorphan Associated with the Inhibitory
Action on H-DA Uptake
















by methadone and dextrorphan (each 1 pM). Again, the sites of
action of methadone and dextrorphan associated with the
inhibitory effect on 3H-D A uptake may be very similar.
4.5 Effect of Naloxone on Methadone Inhibition of Synaptosomal
Uptake of Radioactive Catecholamines
Fig. 4.13 shows that naloxone was unable to block the
inhibitory action on 3H-NA in synaptosomes. On the contrary,
naloxone potentiated the action of methadone in all the
concentrations tested. Naloxone was used at a concentration
five times that of methadone. In the case of 3H-DA uptake (Fig
4,14) -naloxone. had no effect on the inhibitory action of
methadone on the uptake of 3H-DA, nor did it potentiate the
action of methadone. The latter finding is in agreement with
the observation that naloxone is a weak inhibitor for the
3 L-DA uptake (Fig. 4.6).
4.6 Release of Radioactive Catecholamines from Synaptosomes
Synaptosomes preloaded with 3H-NA or 3H-DA were incubated
at 25°C separately, under the following two conditions:
spontaneous release and stimulated release in the latter,
release was evoked by high K+ concentration (56mM) and in a
Na+-depleted medium. The methods adopted are similar to that
of 5-HT release.
Methadone
Figc 4,13 Effect of naloxone on methadone inhibition of
NA uotake in rat brain synaptosomes» Several
concentrations of methadone (shaded bars) were
tested, and naloxone at five times the concent¬
ration of methadone represented by dotted bars
was added. Blank bar denotes the control. Naloxone
potentiates the inhibitory action of methadone on
NA uptake.
Methadone1
Fig, Inability of naloxone to alter methadone inhibition
of dopamine uptake in rat brain synaptosomes.
Several concentrations of methadone (shaded bars)
were tested, and naloxone at five times the concent¬
ration of methadone failed to antagonize the
inhibitory action of methadone on DA uptake (dotted
bars). The control is represented by a blank bar.
95
Fig. 4.15 shows the time-courses of 3H-NA release under
the above two conditions. The rate of spontaneous release in
the first 5 min was very rapid and about 22% of the total
was released from the preloaded synaptosomes. Release stimulated
by high K+ and Na+-free medium was much greater and amounted
to--4-8% of the total in 5 min. Release of accumulated 3H-DA
followed a similar pattern as the release of 3H-NA from
synaptosomes (Fig. 4.16). Rate of spontaneous release was 15%
of the total in 5 min in the charged synaptosomes. Release of
3H-DA from depolarized synaptosomes by 56 mM K+ in a Na+_ free
medium was 62.5% of the total much greater than the spontaneous
release.
Table 4.5 shows the effect of narcotic drugs on the.
release of 3H-NA from brain synaptosomes in 5 min. The opiate
agonists methadone and morphine inhibited the spontaneous
release of 3H-NA by 11.5% and 13.2% respectively. Other drugs
had no significant effect on 3H-NA release. However, all the
drugs, except the inactive opiate dextrorphan, stimulated the
release of 3H-NA from depolarized synaptosomes evoked by
high K+ and Na+- depletion.
Table 4.6 shows the effect of narcotic drugs on the
release of 3H-D A from brain synaptosomes. For both spontaneous
release and stimulated release, all the drugs, except
dextrorphan, exhibited stimulatory effect on the release of
3H-D A. In general, stimulatory effect was more obvious in
Fig. 4- o 1' Time course of H-NA release from rat brain synapto-
somes« represents spontaneous release of
%-NA( denotes K -induced release of H-NA
in Na -free medium, Release of H-NA was effected by
incubating preloaded synaptosomes for different
periods of time. Relative amount of H-NA released
is expressed as percent of H-NA remaining m the
synaptosomes.
Time <min>
r _i_g e 4, I o 'Time course of H-DA release from rat brain
syrautosomes. represents spontaneous
3
release of H-DA, denotes 1'-induced release
of R-jA m -.a -free medium. Release of H-DA was
•effected by incubating oreloaded synaotosomes foi
different periods of time Relative amount of
H-DA released is expressed as percent of H-DA




Effect of Opiates on the Release of H-NA
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Release in High K and Na -free medium
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Table 4.6 Effect of Opiates on the Release of H-DA
from Rat Brain Synaptosomes
Stimulation of Release of 3H-DA(%]






















Release in physiological medium
Release in high K and Na -free medium
Significant difference from control, p0.0~
stimulated release than'in spontaneous release of H-DA.
4 .7 Discussion
The uptake processes of H-NA and H-DA in rat brain
synaptosomes are saturable and the rates of uptake of these
two radiolabelled catecholamine neurotransmitters follow the
Michaelis-Menten kinetics. These findings suggest that the
transport processes of H-NA and H-DA are carrier-mediated.
Kinetic analyses by means of Lineweaver-Burk plots on the
transport of H-NA and H-DA in brain synaptosomes reveal
that the Km and Vmax for the NA uptake system are 0.19 yM
and 3.08 pmolmg protein min respectively and the Km and
Vmax of the DA uptake system are 0.20 yM and 3.0 pmolmg
proteinmin respectively. Despite the similarities of the
kinetic parameters of these two systems, they are distinct
processes as it has been shown that the NA uptake process
is very sensitive to tricyclic antidepressant inhibition while
tricyclic antidepressants are ineffective in inhibiting the
dopamine uptake. For example, desipramine is approximately
one thousand times less potent as an inhibitor of dopamine
uptake than of NA uptake (Horn et al., 1971).
Opiate agonists, antagonists and opioid peptides tested
all inhibit the uptake of H-NA and H-DA in rat brain
synaptosomes. As in inhibition of 5-HT uptake, methadone
(ICj-n= 1.50 x 10 M) is the most potent inhibitor of H-NA
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and 3H-DA, while dextrorphan (IC 50= 2.00 x 10- 5 M) and
levallorphan are less active. However, met-enkephalin and
leu-enkephalin are more potent inhibitors than morphine and
naloxone on catecholamine uptake. Since dextrorphan, which
practically has no analgesic action in intact animals, is
quite effective in inhibiting 3H-NA and 3H-D A uptake in low
concentration (10-8M), it is not very likely that opiate-
induced changes in transport of neurotransmitters across
presynatic nerve terminal membrane play a primary role in the
mechanism of action of the narcotic analgesics. This suggestion
is supported by the fact that fairly high concentrations of
narcotic drugs are required to produce inhibitory effects
(Ciofalo, 1972). It has been shown by Clouet and Williams (1973
that when radiolabelled narcotic drugs in pharmacologically
active doses were injected through the intra-cisternal route
into rats, methadone, meperidine, naloxone, nalorphine,
levorphanol, morphine and dihydromorphine were localized in
nanomole amounts in the nerve-endings isolated from 1 g of
brain. Thus, the opiate effects'at 0.1 mM concentration would
seem to be unrelated to the activity in vivo of the drugs.
However, the concentration of drug at receptor site, which
is the unknown factor, must be known before the relevance of
the effects in isolated nerve-ending particles to the mechanism
in vivo can be assessed. The presence of nonsynaptosomal
elements in the synaptosornal preparations may result in a
large non-specific inactivation of the drug by non-specific
binding, requiring more drug for in vitro activity than for
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activity in the body.
Among the opiates tested, methadone and dextrorphan are
the most potent inhibitors of uptake of 3H-NA and 3H-DA.
With respect to their IC50 values, methadone is twice more
potent than dextrorphan in inhibiting 3H-DA uptake, while for
the uptake of 3H-NA, methadone and dextrorphan are equally
potent (IC 50 values are in the order of 10-5 M). Both drugs
exhibit inhibitory action on the uptake of 3H-NA and 3H-DA
in a range from 10-8 M to 10-4 M. At low drug concentrations
(below 10-5M for the uptake of 3H-NA and below 10-6 M for the
uptake of 3H-DA) dextrorphan is more potent than methadone
for inhibiting the uptake of radiolabelled catecholamines,
but the reverse is true at high drug concentrations. Indeed,
Dixon plots calculated using data obtained with higher drug
concentrations show that the inhibition constants Ki of
methadone are smaller than that of dextrorphan for both
uptake of 3H-NA and 3H-D A, indicating that methadone is the
more potent uptake inhibitor when compared with dextrorphan.
The significance of this observation is not clear at present.
Both drugs inhibit the uptake of 3H-NA and 3H-DA in a
competitive manner as they decreased the affinity between the
substrate amine and the amine carrier without altering the
Vmax values of these systems. As dextrorphan, an inactive
opiate, was as active as methadone, an active opiate, in
inhibiting the uptake of 3H-NA and 3H-DA, it is likely that
these two drugs do not affect catecholamine uptake by
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interacting with opiate receptors. This thought is supported
by the finding that naloxone, as opioid antagonist failed to
reverse the inhibition. As both drugs affect catecholamine
transport by lowering the affinity of the carriers for their
respective substrates, it seems that the site(s) of action
of these two drugs may be very similar or closely related.
Several reports have shown that narcotic analgesics
inhibit the release of various neurotransmitters in the CNS.
For instance, morphine depresses the potassium-induced
release of 3H-dopamine from slices of rat striatum (Celsen
and Kuschinsky, 1974 Loh et al., 1976 Starr, 1978). This
effect is blocked by the opiate antagonist naloxone and is
probably due to the activation of inhibitory opiate receptors
located on dopaminergic nerve endings of the rat brain
(Polland et al., 1977). Taube et al. (1976) have shown that
enkephalin reduces noradrenaline release from rat cortex
slices, the effect being antagonized by naloxone. In agreement
with these reports, met- and leu- enkephalin inhibited the
K+- induced release of 3H-NA and 3H-DA in the presence of
Na+ by 20-30% (data not shown).
However, in high K+ and sodium-free medium, the opiate
agonists, antagonists and the two enkephalins all stimulate
the release of 3H-NA and 3H-DA from preloaded synaptosomes
prepared from whole rat brain. For instance, methadone,
morphine, naloxone, levallorphan, met-enkephalin and leu-
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enkephalin stimulate the induced release of 3H-NA, as well as
the spontaneous and induced release of 3H-DA. With the
exception that methadone and morphine inhibited the spontaneou
release of 3H-NA. This discrepancy on the action of narcotic
analgesics on the induced release of 3H-NA and 3H-D A may be
due to the different methodologies employed. First, the
present experiments use Na+-free medium in the release studies
It has been suggested that opiate receptors are involved in
the modulation of neurotransmitter release, depletion of Na+
may affect the activation of the inhibitory opiate receptors
located on the nerve endings. Moreover, it has been shown that
in a Na+-free medium, carrier-mediated outward transport plays
an important part in the release of neurotransmitters. In
the presence of Na+, exocytosis is the major release process
induced by high KIt is probable that the observed effect
of opiates on the K+-induced release of transmitters in Na+-
depleted condition is due to the combined action of the carrier
mediated outward transport and exocytosis associated with the
activation of the inhibitory opiate receptors. Secondly,
whole brain synaptosomes were used in the present experiments,
whereas other investigators employed brain slices prepared
from various brain regions. Thus, the possibility of regional
differences or specificities cannot be excluded. Moreover,
there is controversy on the ability of met-enkephalin and
-endorphin to reduce the release of 3H-DA from the rat
striatum. Loh et al. (1976) found that in the rat striatum,
-endorphin is at least 2 times more potent than morphine,
107
whereas Arbilla and Langer (1978) reported these opiate
agonists were unable to reduce the potassium-evoked release
of 3H-DA from rat striatum. In addition, several investigators
reported that met-enkephalin has no inhibitory effect on the
release of DA from rat striatum (Loh et al., 1976 Arbilla
and-Langer, 1978), whereas Subramanian et al. (1977) have
claimed this opiate.agonist reduces the potassium-evoked
overflow of 3H-DA from corpus striatum. Though our data are
at variance with some earlier reports on catecholamine release,
nevertheless the finding that dextrorphan had no significant
effect on the induced release of 3H-NA and 3H-DA from
preloaded synaptosome appears to support the concept that
opiate receptors may be involved in the mediation of
catecholamine release at nerve terminals.
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CHAPTER V EFFECT OF OPIATES ON THE TRANSPORT OF GABA, GLUTAMIC
ACID AND ADENOS INE IN RAT BRAIN S YNAPTOS OMES
5.1 Introduction
Neurophysiologic studies suggest that certain amino acids
may be major excitatory or inhibitory neurotransmitters in the
mammalian central nervous system. Glutamic acid, when applied
iontophoretically, excite most central neurons (Curtis and
Watkins, 1960 Krnjevic and Phillis, 1963) while y-aminobutyric
acid (GABA) mimics the effects of the natural inhibitory
transmitter in mammalian cerebral cortex (Krnjevic and Schwartz,
1967).
Similar to the biogenic amine story, specific high-affinity
uptake mechanisms have been described for GABA and glutamic
acid in nervous tissues (Iversen and Neal, 1968 Logan and
Snyder, 1971). Many investigators demonstrated that the uptake
of 3H-GABA and 3H-glutamic acid in rat cerebral cortex and
homogenate was mediated by a saturable process, which is
energy-, temperature- and sodium-dependent. These transport
processes have Km values in the order 10-5 M, indicating
the high-affinity nature of these two systems, other low-
affinity amino acid uptake systems have Km values of 10-3 M
to 10-4 M (Blasberg, 1968). Moreover, Logan and Snyder (1971)
showed that GABA and glutamic acid are taken up at nerve
terminals by these distinct higher affinity systems, which
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act as inactivation of transmitter substances. Furthermore,
Iversen and Johnston (1971) have shown that the uptake of
3H-GABA in tissue homogenates was associated with osmotically
sensitive particles with characteristics of synaptosomes.
Electron microscope autoradiographic studies of 3H-GABA uptake
have provided direct evidence that synaptosomes are the
principal sites of GABA uptake in homogenates (Bloom and
Iversen, 1971). It has been shown that transport of glutamic
acid and GABA,a metabolite of glutamic acid, occurs in different
population of neurons, since GABA concentrations as high as
10-3 M failed to reduce synaptosomal 3H-glutamic acid uptake
(Logan and Snyder, 1971).
As putative neurotransmitters in the CNS, GABA and
glutamic acid have been demonstrated to be released from nerve
terminals in response to neural stimulation. For instance,
electrical stimulation (Hillmann et al., 1963) markedly increased
the efflux of radiolabelled GABA and glutamate from both rat
striatal (Katz et al., 1969) and cortical slices (Hammeratad
and Cutler, 1972). High concentrations of potassium ions
between 40 and 100 mM have also been shown to increase the
efflux of radiolabelled GABA from slices of rat cortex (Collins
and Topiwala, 1974 Davies et al.,1975) and glutamate from
striatal slices (Katz et al., 1969). Moreover, the demonstration
that these two amino acids are released from synaptosomes
(Levy et al.,l973 Raiteri et al., 1975 Redburn et al., 1976),
but not from myelin or microsomal fractions (Levy et al., 1973),
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strengthens the view that nerve terminals are the sites of
release.
Adenosine has been proposed as a putative inhibitory
transmitter or modulator in the central nervous system. The
central effects of iontophoretically applied purine nucleosides
and nucleotides has been examined (Phillis et al., 1975 a,b
1979 and Kestopoulos et al., 1975). The most pronounced action
of adenosine and adenine nucleotides on deep, spontaneously
firing cerebral cortical neurous was to decrease the rate
of spontaneous discharge. Similar depressant actions of
adenosine were observed on evoked potentials in olfactory
cortical slices (Kuroda et al., 1976 Scholfield, 1978).
The idea of adenosine being a neurotransmitter or
neuromodular in the CNS was strengthened by demonstrations
of its release, in a calcium-dependent manner, from a variety
of in vivo and in vitro brain preparations (Kuroda and
Mcllwain, 1974 Sulakhe and Phillis,1975 Daval et al., 1980).
Moreover,D aval et al.(1980) reported that potassium-evoked
release from cortical synaptosomes was unaffected by the
sodium channel blocker, tetrodotoxin which is consistent with
the view that potassium caused a direct depolarization
independent of sodium entry.
The adenosine uptake system has been studied in various
CNS preparations in vitro. Shimizu et al. (1972) demonstrated
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the presence of a high-affinity adenosine uptake (Km 191JM)
in guinea-pig brain slices. Preferential uptake of adenosine
over adenine and inosine into synaptosomal beds has been
demonstrated in guinea-pig neocortical tissue (Kuroda and
Mcllwain, 1974). This finding supports the presence of a
specific adenosine uptake system in nervous tissue. Moreover,
the uptake of adenosine in brain tissues can be prevented or
reduced by various inhibitors such as dipyridamole, diazepam,
hexobendine and papverine (Mah and Daly, 1976 Huang and I aly,
1974). In agreement with this finding is the report that these
inhibitors potentiated the depressant action of adenosine
when applied iontophoretically (Phillis et al., 1979 Phillis,
1979). Altogether the above observations suggest that the
adenosine uptake system at nerve endings plays an important
role in terminating its action in the CNS.
5.2 Uptake of .5 H-GABA in Rat Brain Synaptosomes
Fig. 5.1 shows the time-course of 3H-GABA uptake in
synaptosomes, uptake was saturated at 30 min, at this time
6.1 nmol/mg protein of GABA was accumulated. Fig. 5.2 shows
the effect of opiates on the uptake of 3H-GABA. All drugs,
at a concentration of 25 urn, inhibited the uptake process
slightly. Among the drugs tested, the opioid peptides met-
enkephalin and leu-enkephalin were very potent inhibitors
while levallorphan was least active.
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Time course of 3H-GABA uptake into rat brainFig, 5,1
synaptosomes. 3H-GABA (10-5M) was incubated with
synaptosomes until uptake of 3H-GABA was saturated.
Each point is the mean± S.D. of three separate
experiments in triplicate. Standand deviations are
lower than 4%.
Time m in
Fig. 5.2 Effect of opiates on 3H-GABA uptake into rat brain
synaptosomes0 Opiate drugs at a concentration of
2,5 x 10-5 v M were incubated with H-GABA (10-5 M)
for 30 inin. Inhibition of 9H-GABA uptake by opiates
is expressed as percent of control uptake.
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5.3 Release of 3H-BABA from Synaptosomes
Spontaneous release of 3H-GABA was slow and small, only
10% was released at the end of 30 min (Fig. 5.3). However,
induced release of 3H-GABA in high K+ and Na+-depleted medium
was much greater (Fig. 5.3). At 1 min, 63% of the preloaded
GABA was released, then the rate of release levelled off.
Table 5.1 shows the effect of opiates on release of 3H-GABA
from brain synaptosomes. It may be observed that spontaneous
release of 3H-GABA was not affected by these drugs. However,
high K+ induced release was stimulated by morphine and the
two opioid peptides met-enkephalin and leu-enkephalin.
Methadone, dextrorphan and the antagonists naloxone and
levallorphan did not have significant action on the induced
release.
5.4 Uptake of 14C-Glutamic Acid in Rat Brain Synaptosomes
The uptake of 14C-glutamic acid in synaptosomes was
saturated at 30 min, and 15.0 nmol/mg protein of glutamic
acid was accumulated (Fig. 5.4). As shown in Fig. 5.5, opiates
at a concentration of 25pM inhibited slightly the uptake of
14C-glutamic acid. Levallorphan was ineffective.
5.5 Release of 14C-Glutamic Acid from Synaptosomes
Fig. 5.6 shows the time-course of 14C-glutamic acid
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Time course of 3H-GABA release from rat brainFig. 5.3
synaptosomes. (D--D) represents spontaneous release
of 3H-GABA, (0-0) denotes K+- induced release of
3H-GABA in Na+-free medium. Percent of 3H-GABA
remaining in the synaptosomes reflects the amount
of 3H- GABA released,
y i m e mi n
Table 5.1 Effect of Opiates on the Release of H-GABA
from Rat Brain Synaptosomes
Stimulation of Release of H-GABA(%)























Release in physiological medium
Release in high K and Na -free medium
it
Negative number denotes inhibition of release
•k
Significant difference from control, p0.05
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Time course of 14C- glutamic acid uptake into ratFig. 5.4
brain synaptosom.es. 14C-glutamic acid (3.6 x 10-5 M)
was incubated with synaptosomes until uptake of
14C-glutamic acid was saturated. Each point is the
the mean of three separate experiments in triplicate.
Standard deviations are smaller than 4%.
1
Fig. 5.5 Effect of opiates on 14C-glutamic acid uptake into rat
brain synaptosomes. Opiate drugs at a concentration of
2.5 x 10-5 M were incubated with 14C-glutamic acid
(3.6 x 10-5 M) for 30 min, Inhibition of 14C-glutamic




Time course of C-glutamic acid release from rat
brain synaptosomes. represents spontaneous
1 L
release of C-glutamic acid, denotes K-
induced release of C-glutamic. acid in Na -free
1 L
medium. Percent of C-glutamic acid remaining in





release. The rate of spontaneous 14C-glutamic acid release
was rapid during the first 5 min and then levelled off and at
30 min 27.5% of the preloaded 14C-glutamic acid had been
released. 14C-glutaminc acid release was particularly sensitive
to high K+ and Na+-free condition, one minute incubation
resulted in 77% of release. At the end of 30 rein, only 4% of
the preloaded glutamic acid remained. Table 5.2 shows that
morphine at a concentration of 25pM slightly inhibited the
spontaneous release of 14C-glutamic acid while other opiates
had no significant effect. On the other hand, all the opiates,
excepting dextrorphan, the inactive opiate, stimulated the
induced release of 14C-glutamic acid and methadone and
morphine being most potent.
5.6 Effect of Opiates on Uptake of Non-transmitter Amino
Acids in Rat Brain Synaptosomes
In order to test whether the inhibition effect of opiates
on the uptake of amino acid neurotransmitters is specific
or not, other neutral and basic amino acids including some
of the precursors of amine transmitters are also investigated.
Table 5.3 shows that opiates also affected the uptake of
these amino acids in synaptosomes. All opiate agonists,
antagonists and opioid peptides inhibited the uptake processes
of these amino acids. In general, among the drugs, the peptides
met-enkephalin and leu-enkephalin are most potent in inhibiting
the uptake of these amino acids. The effects of the opiates
Table 5.2 Effect of Opiates on the Release of C-Glutamic
Acid from Rat Brain Synaptosomes
Stimulation of Release of C-Glutamic Acid
Drug (25yM)
cl






















Release in physiological medium
Release in high K and Na -free medium
Negative number denotes inhibition of release
Significant difference from control, p0.05
Table 5.3 Effect of Opiates on Uptake of Amino Acids in Rat
Brain Synaptosoraes
Inhibition of Uptake(%)



























































in the inhibitory uptake process appears to be specific
as they inhibited the uptake of different amino acids tested
to different degrees.
5.7 Uptake of 3H-Adenosine in Rat Brain Synaptosomes
Fig. 5.7 shows that the uptake of 3H-adenosine in
synaptosomes was saturated at approximately 40 min, and at
this time 107.1 pmol/mg protein of adenosine was accumulated.
Opiate agonists and antagonists inhibited the uptake of
3H-adenosine by 22 to 32% (Fig. 5.8).
5. 8 Release of 3H--Adenosine fromd Syna.ptosomes
Fig. 5.9 shows the time-course of 3H-adenosine release
from synaptosomes. Depolarization induced by high K+
stimulated the release process. By 30 min, 59.5% of the
preloaded 3H-adenosine had been released, compared with the
24% in the case of spontaneous release. As shown in table 5.4,
except morphine which inhibited the spontaneous adenosine
.release by 10.2% and stimulated the high K+ induced release
by 13.1%, other opiates tested at 25 uM had no significant
inhibitory or stimulatory effect on either the spontaneous
or depolarization-induced release of 3H-adenosine.
5.9 Discussion
High-affinity uptake of 3H-GABA and 3H-glutamic acid and
Fig, 5,7 Time course of H-adenosine uptake into rat brain
synaptosomes. H-Adenosine (10 M) was incubated
with synaptosomes until saturation of H-adenosine
uptake had been attained. Each point is the mean t
S.D. of three separate experiments done in triplicate
Standard deviations are smaller than h%,
TIME<min>
Fig.5.8 Effect of opiates on 3H-adenosine uptake into rat
brain synaptosomes. Opiate drugs at a concentration
of 2.5 x 10-5 M were incubated with 3H-adenosine
(10 M) for 4-0 min. Inhibition of H-adenosine
uotake by opiate is expressed in percent control
uptake.
Fig 59 Time course of H-adenosine release from rat brain
synaptosomese represents spontaneous release
of H-adenosine. denotes K -induced release
of 'H-adenosine in Na -free medium. Amount of
H-adenosine released is calculated by measuring
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Table 5.4 Effect of Opiates on Release of H-Adenosine
from Rat Brain Synaptosomes
3
Stimulation of Release of H-Adenosine(%)























Release in physiological medium
Release in high K+ and Na+-free medium
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Negative number denotes inhibitioh of release
X
Significant difference from control, p0.05
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3H-adenosine by whole rat brain synaptosomes has been
described. The uptake of these neurotransmitters follow a
saturable fashion, indicating these systems are carrier-
mediated.
..,Release of 3H-GABA, 14C-glutamic acid and 3H-adenosine
from preloaded rat brain synaptosomes was demonstrated. In
general, the rate of spontaneous release of 14C-glutamic
acid and 3H-adenosine was greater than that of 3H-GABA.
Moreover, high K± -induced 14C-glutamic acid release was faster
than those of K+-induced release of adenosine and GABA.
Several lines of evidence suggest that central analgesic
action may be related to GABA.ergic neurotransmission. Thus,
it has been reported that acute administration of morphine
induces regional changes of GABA levels in the brain (Lin
et al., 1973) chronic administration to dogs results in
elevated levels of GABA in the hypothalamus and sub-cortex
(Lin et al., 1973). Moreover, both morphine tolerance and the
morphine withdrawal syndrome in mice are enhanced by exogenous
administration of GABA (Ho et al'.,, 1973). In agreement with
this school of thought, present experiments show that opioids
affect the synaptic events in GABAergic neurons by inhibiting
the uptake of 3H-GABA in rat brain synaptosomes. In particular
met- and leu-enkephalin are most potent among the opiates.
This is of special interest as there are reports suggesting
an interaction between enkephalinergic neurons and GABAergic
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neurons. Thus, Biggio et al.(1977) showed that GABA agonists
potentiate the analgesic actions of morphine in the rat and
that pharmacological manipulations of the GABAAergic activity
modify the development of tolerance and physical dependence
to morphine in mice (Ho et al., 1976). More direct interaction
between opioids and GABAergic neurons has been reported by
Moroni et al., (1978). These investigators found that injection
of various doses of morphine (subcutaneously) or of Q-endorphin
(intraventricularly) decreased the turnover rate of GABA in
nucleus caudatus but increased the turnover rate in globur
pallidus and subst-antia nigra. These changes are dose related
and can be inhibited by nalrexone.
Brennan et al. (1980) have shown that met-enkephalin
(10-12- 10-6 M) inhibited the K+-stimulated release of
3H-GABA from rat brain synaptosomes in a dose-dependent manner.
This inhibition effect was antagonized by naloxone. They
suggested the existence of opiate receptors on GABAergic nerve
terminals through which the release of GABA may be modulated.
Surprisingly, our results show that morphine, met-enkephalin and
leu-enkephalin at a concentration of 25iM stiumlate the induced
release of 3H-GABA in a high K+ and Na+-free medium. The reason
for the difference is not clear, however, the di f fer_ ence may
be due to the fact that Na+-free medium was used in the present
study to prevent re-uptake which might otherwise occured
during the release.
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There is little evidence for interaction between narcotic
analgesics and glutamic acid-mediated central actions. In line
with this thought, our studies show that the opioids inhibit
the uptake of 14C-glutamic acid slightly at a drug concentration
of 25 UM. Concerning glutamic acid release, the opiates
tested had no significant effect on the spontaneous release,
however, both methadone and morphine were rather active in
stimulating the K+- induced release of glutamic acid. It is
not clear at this point whether the modulation of 14C-glutamic
acid release is mediated by opiate receptors. But as dextrorphan
failed to affect the release of 14C-glutamic acid, it seems
that the K induced release may be related to opiate receptors.
Besides GABA and glutamic acid, the opiates also inhibited
the uptake of neutral and basic amino acids. In general, met-
enkephalin and leu-enkephalin are more potent uptake inhibitors
than other opioids tested. The potencies of the enkephalins
in inhibiting the uptake of these amino acids are greater than
that of GABA and glutamic acid. One interesting observation
is the fact that both peptides affects the uptake of those
biogenic amine precursors, namely try, tyr. and His. These
findings suggest the opioids affect both neurotransmission
associated with GABA and glutamic acid, and the general
metabolic functions of various amino acids. In the latter case,
opiates not only limit the availability of amino acids for
general metabolic functions in the CNS, they also lower the
availability of precursors for biogenic amine biosynthesis.
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It has been suggested that centrally active drugs may
exert some of their actions through purine-linked mechanisms.
In relation to this proposal Phillis and Kostopoulos (1975)
suggest that the central stimulant effects of caffeine and
theophylline may result from the antagonism of adenosine action
at the receptor level and antidepressants may exert their
central action by potentiating the depressing actions of
adenosine at cerebral cortical neurons. They further suggest
that antidepressants affect adenosine neurotransmission,
by altering the uptake and/or release of adenosine.
Interaction between opioids and adenosine is indicated
by the findings that theophylline, an antagonist of adenosine,
reduces the analgesic effect of morphine in mice (Ho et al.,
1973), and in morphine-dependent rats theophylline enhances
the ability of naloxone to precipitate symptoms of morphine
abstinence (Collier et al., 1974). In addition, both caffeine
and theophylline enhance the effects of nociceptive stimulation
in rats (Paalzow and Paalzow, 1973), possibly by antagonizing
the actions of endogenous opioids. These observations indicate
that morphine may exert some of its actions by enhancing
purine release or by inhibiting adenosine uptake. Our studies
with rat brain synaptosomes show that opiate agonists,
antagonists and the enkephalins, at 25iM, inhibited the uptake
of 3H-adenosine into synaptosomes. Moreover, morphine at this
concentration inhibits the spontaneous release of 3H-adenosine,
but stimulates the induced release of 3H-adenosine from
synaptosomes.
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CHAPTER VI INTERACTION OF ADENOSINE WITH VARIOUS NEURO
TRANSMITTERS IN THE CENTRAL NERVOUS SYSTEM
6.1 Introduction
There is increasing evidence that adenosine may play
a modulatory role in the CNS. For example, adenosine is a
potent activator of adenylate cyclase in several parts of the
brain (Sattin and Pall, 1970 Premont et al., 1977) and has
been domonstrated•to decrease neuronal firing when applied
iontophoretically (Phillis and Kostopoulos, 1975). In addition
intracerebral administration of adenosine has been reported
to affect behaviour (Haulica et al., 1973).
Moreover, interactions between adenosine and various
neurotransmitters have been reported. For instance, adenosine
has been shown to depress the spontaneous and evoked release
of acetylcholine at the rat phren'ic nerve-diaphragm junction
(Ginsburg and Hirst, 1972). In studies on acetylcholine releasc
from intact and isolated cerebral cortical tissues, adenosine
(10-6 M- 10-4 M) has been shown to inhibit the spontaneous
release of acetylcholine from the intact guinea-pig neocortex
and this effect was antagonized by theophylline (Jhamandas
and Sawynok, 1976), while theophylline by itself failed to
modify the rate of acetylcholine release. Adenosine also
inhibited the potassium induced release of rdiolabelled
139
noradrenaline from cerebral cortical slices and of labelled
acetylcholine, dopamine and 5-hydroxytryptamine from striatal
slices (Harms et al., 1978,1979). In general, the effect
was not pronounced and that theophylline blocked these
inhibitory effects.
Modulation of transmitter release by adenosine has been
demonstrated however, effect of.various transmitters on
adenosine release are less documented. Moreover, not much
studies have been carried out on the interaction of the
uptake events of adenosine with various neurotransmitters.
Therefore, the present study was understaken to investigate
.this relationship.
6.2 Effect of Various Neurotransmitters on the Uptake of
3H-adenosine in Rat Brain S naptosomes
Figs. 6.1, 6.2 and 6.3 show the effects of 5-HT, NA and
DA, at various concentrations, on the uptake of 3H-adenosine
in synaptosomes. These three transmitters exerted significant
inhibitory effect on the uptake of 3H-adenosine, at a
concentration as low as 0.1 iiM, and higher concentrations of
monoamines produced larger inhibitory effect. Table 6.1 shows
the effect of GABA and glutamic acid on the uptake of 3H-
adenosine in synaptosomes. It could be observed that GABA
inhibited the uptake of 3H-adenosine by approximate 22%
however, it did not show any dose relationship in the range of
Fig, 6,1 Dose response of 5-HT on inhibition of H-adenosine
uptake in rat brain synaptosomes. Dosage from 10 M
to 10 M of 5-HT was tested. Each noint represents
the mean of three experiments done in triplicate.
Standard deviations are smaller than l+%.
Log Conc. of 5-HT (u M)
Fig. 6,2 Dose response of NA on inhibition of H-adenosine
uptake in rat brain synaptosomes, A dosage from
M of NA was tested. Each ooint
shows the mean of three experiments performed in
triplicate. Standard deviations are less than he.
Log Conc. of NA (u M)
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Dose response of DA on inhibition of 3H-adenosine
Fig. 6.3
uptake in rat brain synaptosomese A dosage from
10-7 M to l0-4 M of DA was tested. Each point denotes
the mean of three experiments performed in triplicate
Standard deviations are less than 4%.
Log Cone of OA uM
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GABA tested. On the other hand, glutamic acid inhibited the
uptake of 3H-adenosine in a dose dependent manner (Table 6.1)
6.3 Effect of Adenosine on Uptake of Various Raduolabelled
Neurotransmitters in Rat Brain Synaptosomes
Figs. 6.4, 6.5, 6.6 show the dose-response curves of
adenosine on the uptake of radiolabelled 5-HT, NA and DA in
synaptosomes. Adenosine inhibited the uptake of these neuro-
transmitters in a dose-dependent manner in the range of 10-7M
to 10-4 M. The inhibitory effect of adenosine on 3H-5HT
uptake
was from 17.6% to 26.2% from 18.3% to 30.6% for 3H-NA
21.7% to 26.3% for 3H-DA. Table 6.2 shows the effect of
adenosine on the uptake of 3H-GABA and 14C-glutamic acid in synapt-
osomes. It was found that adenosine used in the range 10-5M
to 10-4 M did not affect the uptake of 3H-GABA. However, adenosine
inhibited the uptake of 14C-glutamic acid dose-dependently.
6.4 Effect of Various Neurotransmitters on the Release of
3H-Adenosine from Rat Brain Synaptosomes
Table 6.3 shows the effect of the transmitters 5-HT,
NA, DA, GABA and glutamic acid on the release of 3H-adenosine
from synaptosomes. Two concentrations of each transmitter,
10-5M and 10-4 M were tested. For spontaneous adenosine release
only the biogenic amine transmitters stimulated the release
of 3H-adenosine. GABA and glutamic acid were ineffective. The
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Table 6.1 Effect of GABA and Glutamic Acid on the Uptake






5 X 10-5 22.4 20.2
10-5 21.1 16.1
Fig. 64 Dose response of adenosine on inhibition of H-5HT
uptake in rat brain synaptosomes. A dosage from
M of adenosine was employed Each
point represents the mean of three separate experiments
performed in triplicate. Standard deviations are less
than 4$.
Log Conc of Adenosine <u M>
big c 6, f Dose response of adenosine on inhibition of H-NA
uptake in rat brain synaptosomes. A dosage from
10' M to 10 u M of adenosine was employed, Each
point shows the mean of three experiments -performed
in triplicate. Standard deviations are less than
H- 0 o
Log Cone of Adenosine
Fig. 6.6 Dose response of adenosine on inhibition of H-DA uotake
in rat brain synaptosomes, A dosage from 10 M to
10 M of adenosine was tested. Each point shows the
mean of three experiments done in triplicate.
Standard deviations are less than' kl.
Log Co no of Adenosine u IV!
Table 6.2 Effect of Adenosine on the Uptake of H-GABA
and C-Glutamic Acid in Rat Brain Synaptosomes
Inhibition of Untake{%)
Adenosine (M) H-GARA C-Glutamic Acid
Table 6.3 Effect of Various Neurotransmitters on the
Release of H-Adenosine from Rat Brain
Synaptosomes
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Release in physiological medium
Release in high I and Na -free medium
Significant difference from control, p0.05
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same phenomenon occurred in the K induced release of 3H-
adenosine.
6.5 Effect of Adenosine on the Release of Various Neuro-
transmitters from Rat Brain Synaptosomes
As shown in table 6.4, adenosine at the two concentrations
1.5 x 10-5 M and 10-4 M did not significantly affect the
spontaneous release of 3H-NA, 3H-GABA and 14C-glutamic acid.
However, adenosine slightly inhibited the spontaneous release
of 3H-5HT, and slightly stimulated the spontaneous release of
3H-D A. In a high K+ and Na+--free medium, adenosine stimulated
the release-of 3H-5HT, 3H-NA and 3H-D A and adenosine at two
concentrations did not significantly affect the induced release
of 3H-GABA and 14C-glutamic acid.
6. 6 Discussion
Evidence for interactions among various putative neuro-
transmitters in the CNS are supported by experiments that show
overlapping regional distributions of most putative neuro-
transmitters (Friedel, 1973 Hanley and Cottrell, 1974
Samanin and Garattini, 1975). More global drug effects on
central transmitters than originally observed (Costa et al.,
1975 Ladinsky et al., 1976)', and the dependence of various
behaviors on more than one neurotransmitter (Cools and Van
Rossum,1976 Richardson et al., 1971 Singer and Kelly, 1972
Izquierdo, 1974). Moreover, modulation of neurotransmitter
Table 6.4 Effect of Adenosine on the Release of Various Radiolabelled
Neurotransmitters from Rat Brain Svnaptosomes
% Stimulation(+) or Inhibition(-) of Release
Spontaneous Rele£isec Induced ReleaseJ
Adenosine(M)
significant difference from control, p0.05
Neqative number denotes inhibition of rplpa.qp
cRelease in physiological medium
Release m high K and Na -free medium
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release by another neurotransmitter is well documented in the
CNS. For instance, Vizi (1974) and Westfall (1974) showed that
ACh could inhibit CA release in various brain regions, or
vice versa. There is also evidence that adenosine depresses
the release of putative neurotransmitters, such as ACh, 5-HT
NA, DA and GABA from the brain.
The amine transmitters_,, 5-HT, NA and DA interact with
adenosine by inhibiting the uptake of 3H-adenosine into-rat
brain synaptosomes. The inhibition is specific and dose-
dependent in the range of drug concentration from 10-7 M
to 10-4 M. The potencies of inhibition by these amines are
approximately the same, and are comparable to the opioids.
Glutamic acid also inhibits the uptake of 3H-adenosine in a
dose-dependent manner. On the other hand, GABA inhibits the
uptake of 3H-adenosine in a non-dose-dependent manner, possibly
by a non-specific interaction with the neuronal membrane. It is
interesting to note that adenosine used in the concentration
range 10-7 M to 10-4 M also inhibits the uptake of the amine
transmitters, 5-HT, NA and DA, and the amino acid transmitter
glutamic acid in a dose-dependent manner with approximate equal
potency in the reverse case. It should be noted that adenosine
does not significantly affect the uptake of 3H-GABA. In
conclusion, the amine transmitters and glutamic acid potentiate
the action of adenosine and vice versa.
The amine transmitters, 5-HT, NA and DA also regulate
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purinergic transmission by another route: they stimulate the
release of adenosine, therefore facilitating inhibition of
neuronal firing. Amines at concentrations of 10-5 M and 10-4 M
stimulate the spontaneous and induced release( in high K+ and
Na+ depleted medium) of 3H-adenosine from preloaded brain
synaptosomes. The mechanism of the stimulation of adenosine
release is unknown but interference of Ca++ influx may be
one possible candidate. As a matter of fact, GABA and glutamic
acid have no effect on the release of 3H-adenosine from rat
brain synaptosomes. On the other hand, adenosine at concentrations
of 1.5 x 10-5 M and 10-4 M inhibits the spontaneous release of
3H-5HT, but stimulates the spontaneous release of 3H-D A from
brain syna-ptosomes. Spontaneous release of 3H-NA, 3H-GABA
and 14C-glutamic acid is not affected by adenosine. It has
been reported that adenosine slightly depresses the potassium
(20mM) induced release of radiolabelled NA from cerebral
cortical slices and of labelled ACh, DA and 5-HT from striatal
slices (Harms et al., 1978, 1979). Consistent with these reports,
adenosine at a concentration of 100UM inhibited the K+-induced
(.56 mM) release of 3H-NA from cerebral cortex, 3H-DA and 3H-5i1-'T
from corpus striatum by 20% in the presence of Na+ (Data not
shown). However, in high K+ and Na+-free medium, adenosine
(1.5 x 10-5 N and 10-4 M) stiumlated the release of 3H-5HT and
3H-D A from rat brain synaptosomes. Induced release of 3H-GABA
and 14C-glutamic acid is not affected by adenosine. This
discrepancy of adenosine effect on induced release of 3H-5HT
and 3H-D A may be due to the different concentrations of K+
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used (20 mM verus 56 mM) and the absence of Nay in the release
medium. Since it has been suggested that the depressant action
of adenosine on transmitter release may be due to its inter-
ference with the entry of Ca++ into the nerve terminal, as Ca++
plays a major role in excitation-secretion coupling. This
suggestion is supported by the experimental observation of
a decreased 45 Ca uptake into brain synaptosomes depolarized by
K+ in the presence of adenosine (Ribeiro et al., 1979).
Therefore, it is probable that Nat-depletion in the extra-
cellular medium may facilitate the entry of Ca++, so that
adenosine stimulates the induced release of 311-5HT and 3H-DA.
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CHAPTER VII GENERAL CONCLUSION
Uptake of various neurotransmitters into presynatic nerve
endings is carrier-mediated and Na+-dependent. This inward
transport process serves as an inactivation mechanism for
transmitters released into synaptic clefts during neuronal
communications. The energy requir.ed for active transport of
transmitters is mediated by the electrochemical gradient of
Na+ across the neuronal membrane maintained by the activity
of the enzyme Na+- K+-ATPase. Thus, o:abain can inhibit
the active uptake process of transmitters by blocking the
activity of Na+- K+-ATPase.
Release of neurotransmitters from presynaptic nerve
terminals is by exocytosis which is a calcium-dependent
process.-Depolarization of neuronal membrane in high K+
medium evokes the release process. Depletion of Na+ in the
extracellular medium also stimulates the release process,
probably due to the inversion of 'the Na+ gradient. In the
latter case, the release process or the outward transport of
neurotransmitters from synaptosomes is mediated by carrier.
All the opiates, tested at 25 tiM, including agonists
(methadone and morphine), the inactive opiate dextrorphan,
antagonists (naloxo:,e and -levallorphan), and the endogenous
opioid peptides (met- and leu- enkephalin) inhibited the
uptake of neurotransmitters into presynaptic nerve terminals
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Table 7.1 summarizes the results of the effect of opiate on
the uptake of neurotransmitters. It can be observed that
among the opiates, methadone is the most potent inhibitor
for the 5-HT, NA and DA uptake systems, adenosine to a lesser
extent, while the amino acid transmitters, GABA and glutamic
acid, are only slightly inhibited by methadone. The uptake
of 5-HT, NA and DA is inhibited by methadone in a does-
dependent manner. This inhibition is likely caused by the
interaction between methadone and the transport carriers,
as methadone decreases the affinity between the amines and
their respective carriers without changing the Vmax values.
It may be noted that the inhibition of amine transport by
methadone (and the other opiate drugs) is probably not
directly associated with Na+-K+-ATPase since the addition
of opiates at 25 pM does not significantly affect the
enzyme activity (data not shown).
Dextrorphan inhibits the uptake of neurotransmitters in
a manner similar to and with a potency equal to methadone.
For instance, dextrorphan competitively inhibits the uptake
of the amine transmitters 5-HT, NA and DA in a dose-dependent
manner. The inhibition is caused by the interaction of
dextrorphan with the transport carrier, which decreases the
affinities of the amines for their respective amine carriers.
The proposal that the mechanism of inhibition of amine
uptake by methadone is not mediated through the opiate receptors
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is based on the observation that naloxone is unable to
antagonize significantly the inhibitory action of methadone
on amine uptake.Moreover, methadone and morphine likely
exert their actions by binding to different sites on the
neuronal membrane since methadone inhibits amine uptake
competitively, whereas morphine inhibits amine uptake in a
non-competitive manner. Furthermore, while dextrorphan is an
inactive opiate in intact animals, yet it inhibits the uptake
of monoamines even at concentration as low as 10-8 M by
affecting the affinity of the amines for their respective
carriers. This finding indicates that the opiate-induced
changes in the uptake of transmitters into presynaptic nerve
terminals- may not play a primary role in the mechanism of
action of the analgesic drugs. In this connection, it is
of interest to note that dextrorphan and methadone are inactive
or rather weak analgesics and both drugs affect the uptake
of neurotransmitters by decreasing the affinity of the amines
for their respective carriers, while morphine which is an
active analgesic affects the uptake of neurotransmitters by
changing both the Km and Vmax values of the uptake process.
Though it is tempting to draw a conclusion based on this
finding, further studies have to be done to see if this
finding can be extrapolated to other active and inactive
analgesics.
The endogenous opioid peptides, met- and leu-enkephalin,
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inhibit the uptake of amine transmitters, adenosine, GABA
and glutamic acid. significantly (Table 7.1). Monoamines and
GABA have been implicated in the action of analgesics (Sewell
and Spencer, 1975 Lin et al., 1973). As these two peptides
affect all the neurotransmitters tested, and that adenosine
and glutamic acid also show the same effect, it would be
rather difficult to attribute the inhibition of neurotransmittez
uptake to the analgesic and behavioral effects observed with
opiates. However, these findings suggest that neurotransmitters
do interact with one another. It is not certain at present
that interaction between neurotransmitter uptake may play
a role in opiate analgesic mechanism, yet this possibility
should not be overlooked.
In conclusion, the relationship between the analgesic
action of opiates and uptake of various neurotransmitters
may be indirect, that is, however, the effect of these drugs
on the regulation of transmitter levels in the vicinity of
the receptors may be involved in other mechanisms of opiates.
Previous studies have shown that narcotic analgesics
inhibit the release of various neurotransmitters in the CNS.
For instance, morphine depresses the K+-induced release of
3H-D A from rat striatal slices (Celsen and Kuschinsky, 1974
Loh et al., 1976 Starr, 1978),and enkephalin reduces NA
release from rat cortex slices (Taube et al., 1976). The
latter inhibitory effect is blocked by naloxone. This observation,
together with other studies (Atweh et al., 1978) suggest a
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rather specific presynaptic localization of some opiate receptors.
In fact, we have shown that. met- and leu- enkephalin inhibit the
K+-induced release of 3H-NA and 3H-DA from rat brain synaptosomes
in the presence of Na+ (data not shown). However, in a Na+-depleted
medium, opiate drugs, except dextrorphan, stimulate the K+-induced
release of radiolabelled neurotransmitters from preloaded rat brain
synaptosomes (Table 7.2). Several possibilities may account for the
difference. It is known that the presence of Na+ may be important in
regulation of the agonist and the antagonist state of the po tsynapti
opiate receptors (Snyder, 1978). If the presynaptic receptors behave
like the postsynaptic receptors, the changing of opiate receptor
states cannot explain fully the differential effects of opiates on
neurotransmitter release in the presence and absence of Na+. In the
absence of Na+, which favors the agonist state, naloxone was rather
active in stimulating the release of the monoamines and was a rather
weak activator of 5-HT, NA and adenosine release.
The second possibility that has to be considered is the carrier-
mediated outward transport of neurotransmitters. It has been shown
that this system may play a role in neurotransmitter release in
addition to exocytosis (Raiteri et al., 1977). Thus, the absence of
Na+ in the incubation medium will cause an outward flow of the neuro-
transmitter accumulated. If this reasoning is correct, the binding
of active opiates to the presynaptic opiate receptors may somehow
influence the carrier-mediated efflux of neurotransmitters. This
thought can also explain the weak action of dextrorphan, which is
an inactive opiate, in stimulating neurotransmitter release.
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Another possibility may be due to the fact that most of the
investigators in their studies of opiate action on neurotransmitter
release used slices of specific brain areas, while synaptosomes
were used in the present study. It is known that glial cells are
constituents of the slices and that this brain preparation contains
a fair amount of neuronal connections. Furthermore, there may be
two types of neurons possessing either inhibitory or stimulatory
opiate receptors at their presynaptic nerve terminals. When a whole
brain preparation is used in release study, the combined effect
caused by interaction between opiate drugs and these two kinds of
opiate receptors may be observed.
As some of the opiates are active in inhibiting the uptake
and in stimulating the release of neurotransmitter, thus part of the
inhibition of neurotransmitter uptake is likely due to the stimula-
tion of neurotransmitter release. However, this explanation cannot
be generalized as opiates, with the possible exception of morphine,
do not affect the adenosine release significantly. Also, the
inhibitory effect of methadone and dextrorphan on monoamine uptake
is large while their stimulatory effect on monoamine release is
rather slight, therefore, it does not seem that the stimulation of
monoamine release can account to any significant extent for the
huge inhibition of uptake observed.
Careful analysis of the opiate effect on neurotransmitter
release reveals that opiates, whether active or inactive, failed
to affect the release of adenosine (Table 7.2). This finding
suggests that adenosine may not be involved in the central
action of opiates. Also, the inability of dextrorphan, an
inactive opiate, in affecting neurotransmitter release (Table
7.2) supports the idea that presynaptic opiate receptor may
be.important in the central action of opiates.
In conclusion, though opiates modulate the uptake of
neurotransmitters as well as the evoked release of transmitters,
the inhibition of the uptake process is probably unrelated
to presynaptic opiate receptors and the central action
of opiates, while the modulation of transmitter release
by opiates, which appears to be mediated through opiate
receptors, is likely associated with opiate actions in the
brain.
Table 7.1 Effect of Opiates on the Uptake of Radiolabelled
Neurotransmitters in Rat Brain Synaptosomes
Inhibition of Uptake(%)









Table 7.2 Effect of Opiates on the I -induced Release of











Significant difference from control, p0.05
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